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Abstract 
Cardiovascular adaptations to long-term high intensity causes physiological remodelling 
of the Right ventricle (RV) due to frequent exposure to elevated exercise intensity. 
Evidence suggests dynamic exercise training serves as the primarily stimulator for the 
RV adaptation. This cardiac adaption might exceed the cut off limit meeting structural 
criteria for arrhythmogenic right ventricular cardiomyopathy (ARVC) disease. Athlete 
pre-participation screening is focused on detecting pathological conditions like ARVC. 
Current issues include: indices that differentiated ARVC patients and healthy people; 
the impact of different levels of dynamic training exposure on the RV structure, 
function in elite male athletes; insight into the RV structural and functional  in those 
athletes meet the structural TFC (MTFC) for ARVC and those that do not (NMTFC) via 
utilising 12-leads Electrocardiography (ECG) and echocardiography. 
 
 Study one is a systematic review and meta-analysis technique that employed a case-
control design sought to determine the extent of the RV structural and functional ranges 
in ARVC. In second study, athletes were grouped according to their sporting discipline 
using the Mitchell Classification as Low Dynamic (LD), Moderate Dynamic (MD) or 
High Dynamic (HD) and underwent through traditional and novel echocardiography 
techniques with a focused and comprehensive assessment of the RV. In study 3, athletes 
were grouped to MTFC for ARVC and those NMTFC. Study four, retrospective study 
looking at the 12-lead ECG for athletes in study MTFC compared to NMTFC. 
 
The key finding form the first study was a significant differences in a range of structural 
and functional echocardiographic parameters between ARVC patients and healthy 
control participants. Patients with ARVC had larger RV outflow tract (RVOT) diameter 
Abstract 
iii 
 
at short-axis view (mean  SD; 34 vs. 28 mm P<0.001) and RV end-diastolic area (23 
vs. 18 cm
2
 P<0.001) compared to healthy controls. ARVC patients also had lower value 
on conventional and global RV strain (ε) parameters. HD and MD sport disciplines in 
second study had generally larger absolute and scaled RV structural indices than LD 
group. There were no between group differences in conventional RV functional indices 
as well as global RV ε (LD: -23.4 ± 3.1 vs MD: -22.7 ± 2.7 vs HD: -23.5 ± 2.6, %) and 
strain rate (P>0.01). The base to apex ε gradient in the RV septum was lower in the MD 
athletes compared to HD and LD due to a lower apical septal ε which significantly 
correlated with absolute RV chamber size. In third study, MTFC had larger absolute and 
scaled RVOT diameter compared to NMTFC (P ˂0.05) but these athletes did not 
develop a proportional increase in the RV inflow dimensions. MTFC also had lower 
global RV ε, peak systolic and late diastolic tissue velocity compared to NMTFC. Study 
four, MTFC had generally normal ECG finding compared to NMTFC. The finding have 
important implication for cardiovascular screening of athletes. 
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Chapter 1- General Introduction 
1.1 Introduction 
An elite athlete is an individual who is performing at the highest level of their sporting 
discipline (Drezner et al., 2017). Alongside numerous physiological changes, elite 
athletes present with cardiac adaptations in response to high volumes of training that are 
referred to as the 'Athlete's Heart' (AH). The AH describes electrical, structural and 
functional adaptation of all the cardiac chambers (Utomi et al., 2013; Brown et al., 
2017).   
 
In clinical and scientific work the right ventricle (RV) and its character or phenotype in 
the athlete is often overlooked (Ionescu, 2012) and the available descriptive information 
has lagged behind that of the left ventricle (LV) (Voelkel et al. 2006; Sadeghpour and 
Alizadehasl 2015). This is primarily due to the geometric complexity of the RV and the 
challenges associated with non-invasive imaging (Ho and Nihoyannopoulos, 2006). 
Recently, more attention has been devoted to RV assessment based on advancements in 
non-invasive cardiac diagnostic tools such as electrocardiography (ECG), 
echocardiography and magnetic resonance imaging (MRI). These tools have been 
applied to the study of the RV and may play an important role in the differentiation of 
the AH from pathological disease states that affect the right heart (Voelkel et al., 2006; 
Ionescu, 2012).  
 
Recent data has suggested a disproportionate RV adaptation to exercise training when 
compared to changes in the LV, that is potentially related to a greater relative increase 
in RV afterload with exercise (La Gerche and Claessen, 2015a). Exercise causes end 
systolic LV wall stress to increase by 14% whilst in similar conditions the RV wall 
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stress can increase by up to 125%  (La Gerche and Heidbu, 2011). This acute stimulus 
may serve to drive chronic adaptation and results in RV structural, functional and 
electrical changes that can be documented by both echocardiography and ECG 
(Oxborough et al., 2012b; Lord et al., 2014; Utomi et al., 2014; Drezner et al., 2017).  
 
It has been suggested that RV adaptation is primarily influenced by high dynamic 
sporting activity and some studies have highlighted the magnitude and nature of this 
adaptation using conventional echocardiography (Utomi et al., 2013; McClean et al., 
2014; Oxborough et al., 2016; D’Ascenzi et al., 2017b). These data suggest that there is 
enlargement of the RV cavity with a disproportionate increase at the inflow. On-going 
advances in echocardiographic techniques including the development of speckle 
tracking echocardiography (STE) have allowed the assessment of myocardial strain (ε) 
and strain rate (SR) yet there is a lack of data pertaining to this novel assessment of RV 
global and regional mechanics in these athletes. In addition, the extent of any electrical 
remodelling and its association to RV structure in elite athletes is not well understood.   
 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a “primary” disease of the 
heart muscle affecting predominantly the RV, and to some extend the LV.  It is 
characterised by fibrofatty replacement of the myocardial tissue and predisposes an 
individual to the risk of sudden cardiac death (SCD) possibly through the promotion of 
fatal arrhythmias. In the United Kingdom, it has been estimated that 14% of SCD in 
young athletes is attributed to ARVC (Finocchiaro et al., 2016). It has also been 
proposed that the true prevalence of ARVC may be higher than originally thought due 
to the complexities in diagnosing the disease (Sorrell, Kumar and Kalra , 2009). More 
controversially, an ARVC phenotype without genetic cause has been described in a 
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small number of endurance athletes (i.e. high dynamic) raising the possibility that forms 
of ARVC may be acquired through long-term intensive endurance exercise (Harper and 
Mottram, 2009; La Gerche et al., 2010).  
 
The diagnosis of ARVC is made utilising a multi-disciplinary approach as described by 
the revised Task Force Criteria (TFC) (Marcus et al. 2010).  This approach is used in 
pre-participation cardiac screening (PPCS) programmes around the globe to identify 
those athletes that may have underlying disease and an elevated risk for SCD. Both the 
echocardiogram and 12-lead ECG are considered to be fundamental in the TFC and 
their application is important during PPCS (Marcus et al., 2010). The revised TFC was 
written to improve the diagnostic yield of PPCS test compared to the original TFC 
(McKenna et al., 1994). Despite an apparent increase in specificity there are still 
improvements to be made with regards to its sensitivity (Vitarelli et al., 2013).  This 
may in-part be explained by the revised TFC using only RV outflow tract measures to 
reflect chamber size whilst functional criteria are based on a global measure; fractional 
area change (RVFAC) as well as a subjective assessment of wall motion. Based on this 
it is clear that more studies are needed to determine the ranges of RV structure and 
function for conventional and STE derived echocardiographic indices in patients with 
ARVC. In addition, it is important to investigate the effectiveness of utilising the 
revised TFC for athlete populations. 
 
In addition, athletes with RV enlargement might exhibit an increased prevalence of T-
wave inversion (TWI) on 12-lead ECG which present a challenge in the differential 
diagnosis from ARVC (Zaidi et al., 2013b; Drezner et al., 2017). More data is required 
to help aid the differential diagnosis of the AH and ARVC with particular attention to 
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the upper limits of RV structural and functional adaptation in athletes alongside the 
potential role of STE. The addition of STE would provide insight into the mechanical 
function of the RV specifically as myocardial dysfunction leads us to acknowledge that 
specific muscle layers degrade prior to other areas, which in turn may become 
compensatory which means that heart works well enough that person do not notice any 
problems or the symptoms (Iacoviello et al., 2011). This is clearly highlighted in studies 
detecting early onset of RV dysfunction in small populations of patients with ARVC 
with normal fractional area change (FAC) (Teske et al., 2009a; Teske et al., 2012; 
Iacoviello et al., 2011).  
 
1.2 Aim of this Thesis 
The overarching aim of this thesis is to characterise the RV phenotype in elite male 
athletes using standard conventional echocardiography, STE and 12-lead ECG whilst 
determining any phenotypical presentation in those athletes that meet structural and 
functional TFC criteria for ARVC.   
 
This broad aim can be achieved through careful assessment of the following specific 
objectives:   
 
1. To interrogate existing literature to establish ranges for conventional and STE 
derived echocardiographic indices in patients with ARVC. 
2. To determine the impact of sporting discipline, and its dynamic component, on 
RV structure and function as determined by conventional echocardiography and 
STE in a large sample of elite male athletes. 
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3. To assess RV structure and function in elite male athletes who present with 
extreme phenotypical expression of the AH (i.e. meeting structural TFC for 
ARVC) with those athletes who do not present with TFC measures. 
4. To assess resting 12-lead ECG data in elite male athletes who present with 
extreme phenotypical expression of the AH (i.e. meeting structural TFC for 
ARVC) compared to those that don’t meet the TFC. 
 
These aims can be stated as the following null hypothesis: 
 
 H01: Conventional indices of RV function will NOT be different between patients 
with ARVC and healthy controls. 
 H02: STE derived indices of RV function will NOT be different between patients 
with ARVC and healthy controls. 
 H03: There will be no difference in conventional indices of RV structure and 
function across different dynamic sporting disciplines in elite male athletes. 
  H04: There will be no difference in STE derived indices of RV structure and 
function across different dynamic sporting disciplines in elite male athletes. 
 H05: There will be no difference in conventional indices of RV structure and 
function between elite male athletes that meet TFC for ARVC and those athletes 
that do not meeting the structural TFC for ARVC. 
  H06: There will be no difference in STE derived indices of RV structure and 
function between elite male athletes that meet TFC for ARVC and those athletes 
that do not meeting the structural TFC for ARVC. 
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 H07: There will be no difference in resting 12-lead ECG criteria between elite male 
athletes that meet TFC for ARVC and those athletes that do not meeting the 
structural TFC for ARVC. 
 
1.3 Structure of the Thesis 
Following this general introduction, the thesis provides a substantive literature review 
describing; firstly information pertaining to the physiology and assessment of cardiac 
structure and function, with specific attention to the RV. Secondly, the literature review 
develops to provide a discussion on the prevalence of SCD in athletes and the 
importance of pre-participation screening of competitive athletes as a means of lowering 
the risk of SCD from diseases such as ARVC. Particular attention is given to the 
advancement of echocardiographic technology and its role in cardiac screening. The 
review raises questions related to RV adaptation in elite athletes and the paucity of 
research on: 1) influence of different training stimuli on RV structure and function, 2) 
the most common echocardiographic indices used in the assessment of ARVC and 3) 
the role of echocardiography and ECG on the differentiation of ARVC from AH. The 
fundamental role of the literature review is to provide a sound scientific rationale for the 
subsequent empirical studies contained within this thesis.    
 
Chapter three provides a clear description of the general methods that were adopted in 
the empirical studies in this thesis. This includes the echocardiographic and 
electrocardiographic procedures and measurements as well as collection of data 
pertaining to anthropometric assessment. Ethical and informed consent procedures are 
also documented. 
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Chapter 4 is the first empirical study and employs a systematic review and meta-
analysis design to establish the extent and magnitude of conventional echocardiographic 
and STE measures of RV function in patients with ARVC. This provides the 
foundations for which the subsequent studies into the AH can be compared.   
 
Chapter 5 introduces the AH and determines the nature of the RV phenotype in a large 
sample of elite male athletes. The study utilises a cross-sectional design attempting to 
elucidate any differences across athletes of varying sporting disciplines based on the 
specific dynamic component of their training and competition.   
 
Chapters 6 and 7 provide additional insight into the AH by assessing RV structure and 
function in elite athletes with extreme phenotypical presentation of RV dimensions (i.e 
those that meet the structural TFC for ARVC) in comparison to those athletes that do 
not meet structural TFC for ARVC. Chapter 6 focuses on echocardiographic assessment 
whilst chapter 7 raises the question as to whether the 12-lead ECG may be mediated by 
individual variance in RV presentation.  
 
Chapter 8 presents an overarching general discussion of the issues raised across all of 
the studies. The discussion relates to pathological and physiological RV adaptation, the 
role of echocardiography (including STE) and the 12-lead ECG in the athlete PPCS 
setting. Furthermore limitations are discussed and directions for future research are 
introduced. An overall conclusion reflects on the aims and objectives for the thesis set 
out in this section.  
 
Chapter 2 - Literature Review 
 
 8  
 
Chapter 2- Literature Review 
2.1 Human Heart 
The human cardiovascular system is a closed-loop system in which the heart is the 
pump that inputs kinetic energy into the blood stream to ensure circulation to all parts of 
the body. What gets pumped out of the heart returns in the closed-loop system. The 
heart is a muscular organ that consists of two “priming” atria, which sit above the dual 
pumps of the ventricles. The LV supplies blood to the systemic circulation and the RV 
supplies blood into the pulmonary circulation. Because of the proximity of the LV and 
RV as well as the nature of the closed-loop system, any modifications in RV structure 
and function may have a serial and/or parallel impact on delivery of blood to the left 
atria (LA) and thus LV. In addition, any degradation in RV structure or function could 
affect venous return with a subsequent impact on RV filling. The studies contained 
within in this thesis focus on RV structure and function in athletes and those with 
cardiac disease. It is, therefore, pertinent to explore the anatomy of the RV as well as 
the mechanical processes that underpin RV function. 
 
2.1.1 Right Ventricular Structure and Function 
As the heart is rotated in the thoracic cavity, the RV lies just behind the sternum.  The 
inlet to the RV is the tricuspid valve and the outlet is at the pulmonary valve (Figure 
2.1).  
Chapter 2 - Literature Review 
 
 9  
 
 
Figure 2. 1: The three major chamber components: inflow tract (inlet/sinus), 
infundibulum (conus/outflow tract) and apex – TV is the tricuspid valve; PV is the 
pulmonary valve (adapted from  Haddad et al., 2008) 
 
The RV is composed of three areas: 1) the inlet (sinus) portion, which starts from the 
inlet point connecting between the chordae tendinae, the papillary muscles and the 
tricuspid valve, 2) the muscular trabeculations within the apex, and 3) the outlet (conus) 
portion of the infundibulum, which lies just below the pulmonary valve (Figure 2.1).  
 
The myocardial wall of the RV is characterized by being thinner and more compliant 
than the LV and this is largely due to the fact that the RV works against a lower 
afterload and thus is a “lower pressure system” (Sadeghpour and Alizadehasl, 2015). 
The chamber appears as a crescent when viewed in cross-section at the basal level 
(Figure 2.2). In normal conditions, the RV is concave toward the LV enclosing and 
wrapping around the bigger ventricle (Haddad et al., 2008; Aneq, 2011; Sadeghpour and 
Alizadehasl, 2015). 
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Figure 2. 2: Cross-sectional view of the heart at mid-wall level - demonstrating the 
crescent shape of the right ventricle and conical form of the left ventricle. The obliquity 
of the septal muscle structure and its spiral arrangement is clear. Note the thickened 
septum and the wrap around basal loop (adapted from Buckberg and Hoffman, 2014) 
 
There is also a muscular band termed the crista supraventricularis that separates the 
inflow section and the outlet portion and is continuous with the RV free wall. 
Furthermore, there is ventriculo-infundibular fold (a non-fibrotic continuity) between 
wall; the tricuspid and pulmonary valves. The RV wall is also often divided into 6 
sections: 1) anterior, 2) lateral and 3) inferior wall, as well as 4) basal, 5) mid and 6) 
apical sections (Figure 2.3). (Haddad et al., 2008; Aneq, 2011; Sadeghpour and 
Alizadehasl, 2015).  
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Figure 2. 3: Echocardiography view. The lateral (red, blue and purple) and septal 
(yellow, ligh blue and green) wall of the RV is divided into 3 segments each: base 
(yellow and red), mid (blue and light blue) and apex (green and purple) (adapted from 
Aneq, 2011) 
 
The arrangement and the architecture of the myofibres of both the RV and LV form a 
three dimensional network that gives each ventricle its own unique structure (Ho and 
Nihoyannopoulos, 2006). This myofibre arrangement serves to connect both ventricles 
as a helix with two loops. The apical loop provides a structure of the septum and the LV 
wall with ascending and descending oblique fibres and the basal loop structure supports 
the RV free wall and septum with transverse fibres (Figure 2.4). 
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Figure 2. 4: Fiber orientation relationship of the septum composed of oblique fibers 
that arise from the descending and ascending segments of the apical loop surrounded by 
the transverse muscle orientation of the basal loop that comprises the free right 
ventricular wall. Note the conical arrangement of the septum muscle and the basal loop 
wrap, forming the right ventricular cavity (adapted from Buckberg and Hoffman, 2014) 
 
The myofibre arrangement in the RV septum is composed of both superficial and deep 
muscle layers. The superficial muscle fibres have a circumferential arrangement in a 
parallel direction to the inflow region (i.e. atrioventricular groove) and these then turn 
obliquely toward the cardiac apex continuing into the superficial myofibres of the LV 
(Figure 2.5). The deep muscle fibres are aligned longitudinally from base to apex and 
thus longitudinal shortening plays a predominant role in contributing to RV stroke 
volume (RV SV) (Haddad et al., 2008; Aneq, 2011; Brown et al., 2011; Sadeghpour and 
Alizadehasl, 2015). The RV free wall is thin and composed mainly of transverse 
myofibres with some longitudinal muscle fibres in the subendocardial layer (Figure 2.6)  
(Buckberg and Hoffman, 2014). 
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Figure 2. 5: View of the intact heart demonstrating the transverse appearance of the 
right ventricular free wall and oblique fiber arrangement of the underlying anterior 
segment of the apical loop that covers the right ventricular septum and lower left 
ventricular free wall (adapted from Buckberg and Hoffman, 2014) 
 
 
Figure 2. 6: Longitudinal view of the heart showing the thin RV free wall and the 
trabecular RV surface muscle , and thickness of the biventricular septum (adapted from 
Buckberg and Hoffman, 2014) 
 
The RV and LV are connected by: 1) the septum, which presents as a shared wall for 
both ventricles, 2) reciprocal encircling epicardial fibres, 3) a shared pericardial space 
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and 4) attachment of the RV free wall to the anterior and posterior septum. This 
connection between both ventricles presents the anatomic basis of the free RV wall 
traction caused by the LV contraction. This also contributes to ventricular 
interdependence along with the interventicular septum and the pericardium. 
 
The complex gross and myofibre structure of the RV leads to equally complex 
mechanical function with overall RV SV being dependent on specific muscle layers as 
well as LV contractility. Previous work has suggested four mechanisms that underpin 
RV systolic function. Initially, 1) there is the production of a bellow effect due to basal 
loop constriction with 2) concomitant movement of the tricuspid annulus toward the RV 
apex by longitudinal helical shortening. In late systole there is 3) infundibular 
contraction caused by apical loop contraction whilst throughout cardiac cycle the 4) LV 
assists RV contraction via contract of the interventricular septum.  
 
What is important to remember is that in a closed loop system RV output and LV output 
must be equivalent. The fact that the heart achieves this, over a range of levels of 
metabolic activity, given the different size, shape and mechanics of the two ventricles is 
something of a scientific “marvel”. It is also important that both RV and LV can be 
effectively measured and assessed. The odd shape of the RV makes this quite a complex 
and demanding task that will be developed in the next section of the review.  Allied to 
different shapes is the unique way in which each ventricle produces flow. This also 
must be measured as accurately as possible with knowledge it cannot simply imply LV 
functionality (globally or regionally) on the RV. Finally, it has noted that RV function is 
also dependent upon the specific electrical conduction system specific to its anatomical 
regions. This chapter will discuss the basic 12-lead ECG assessment of cardiac 
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electrical depolarisation in the next section as well. This underpins RV function but has 
a key role in athlete screening for the detection of disease. 
 
2.2 Non-Invasive Assessment of Right Ventricular Structure and Function 
 
2.2.1 Transthoracic Echocardiography  
Echocardiography is as a non-invasive technique using ultrasound to image the heart in 
order to assess its structure and function. The technique provides information on 
chamber geometry, valve structure and function as well as myocardial function. Since 
its introduction and the first published study (Edler and Hertz, 1954), the advancement 
in technology has resulted in echocardiography being extensively used in the 
management and evaluation of the patient suffering from cardiac disease (Douglas et al., 
2011).  The development and evolution in echocardiography technology passed through 
various stages from two-dimensional (2D) echocardiographic images, M-mode, 
Doppler, tissue Doppler imaging (TDI) and STE (Edler and Hertz, 1954; Baker, 1970; 
Bom et al., 1973; Griffith and Henry, 1974; Isaaz et al., 1989; Bleeker et al., 2006). 
Collectively these modalities provide an all-inclusive quantitative evaluation of the 
heart. In addition, echocardiography also provides the capacity to comprehensively 
assess RV structure and function (Rudski et al., 2010).  
 
2.2.1.1 Standard echocardiography techniques – 2D and M-mode 
Since both 2D and M-mode echocardiography techniques have been introduced, it has 
been possible to develop a systematic approach to the assessment of the RV. RV 
structure and function is extremely complex with separate infundibulum and marked 
trabeculation making its assessment through echocardiography challenging (Levine et 
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al., 1984; Ho and Nihoyannopoulos, 2006). In this regard, it has been suggested that RV 
structure should be assessed at both inflow and outflow by providing specific 
dimensions from various acoustic windows (Foale et al., 1986). The work by Foale et 
al. (1986) provided RV data pertaining to a healthy population (Foale et al., 1986) and 
was used ubiquitously until a validation study was undertaken in 2008 using cardiac 
magnetic resonance imaging (cMRI) (Lai et al., 2008). Lai et al., (2008) demonstrated a 
very weak association between their dataset (i.e., cMRI) and the Foale’s normal range 
and hence in 2010 the American Society of Echocardiography (ASE) presented a meta-
analysis to provide RV echocardiographic normal ranges (Rudski et al., 2010). This data 
has been adopted by professional guidelines and provides a range of clinically useful 
indices of RV structure and function in a normal healthy population.  While, few 
researchers highlighted the impact of physiological adaptation of the RV (Teske et al., 
2009b; D’Andrea et al., 2011), there is no data identifying the impact of body size 
(Rudski et al., 2010). 
 
A significant challenge has been the application of these techniques to the assessment of 
RV function (Jurcut et al., 2010). Numerous studies have attempted to obtain RV 
volumes and subsequent RV ejection fraction (RV EF) mathematically, but the 
introduction of cMRI provided more accurate gold standard techniques, thus it became 
clear that 2D echocardiography had significant limitations (Helbing et al., 1995; 
Sheehan and Redington, 2008). In view of this, fractional area change (FAC) was 
introduced as a surrogate of RV EF. RVFAC is a measurement of the percentage change 
in RV area between end diastole and end systole from a single plane acquisition (Foale 
et al., 1986). Therefore, the RVFAC provides an index of RV function and appears to 
correlate well with RV EF as determined by cMRI (Anavekar et al., 2007); 
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consequently the ASE recommended RVFAC as part of the assessment process (Rudski 
et al., 2010). Although RVFAC appears to correlate well with RVEF, RV function is 
primarily driven by longitudinal shortening. Based on this, M-mode echocardiography 
has been applied to assess the excursion of the tricuspid annulus (TAPSE). This 
different approach from the apical four chamber view has been shown to have an 
excellent correlation with RVEF when assessed by radionuclide angiography (Bleeker 
et al., 2006). That aside, these techniques are often limited by image quality and do not 
fully represent myocardial shortening and/or function. In order to overcome some of 
these limitations, newer techniques have been developed.  
 
2.2.1.2 Tissue Doppler Imaging (TDI)  
In 1989, utilization of the Doppler technique was used to assess myocardial tissue 
directly (Isaaz et al., 1989). Based on the examination of the high amplitude and low 
velocity signals, TDI works by expressing ultrasound signals from the myocardial 
Doppler signals. A pulsed-wave technique is applied to the annulus of the tricuspid 
valve and provides temporal data of the longitudinal movement of the myocardium and 
thus it can be recorded in both systole and diastole (Nagueh et al., 1997; D’Andrea et 
al., 2010). Pulsed-wave TDI provides measures of Systolic (S'), early diastolic (E') and 
late diastolic (A') myocardial velocities from the RV lateral wall (Pelliccia et al., 2017). 
TDI has been recognised as useful tool with good reproducibility and validity (Bleeker 
et al., 2006; Abraham, Dimaano and Liang, 2007; Sorrell, Kumar and Kalra , 2009; 
Lord et al., 2014). Research affirmed the practicality of TDI by exhibiting the potential 
for evaluation regional myocardial function  (Abraham, Dimaano and Liang, 2007; 
Sorrell, Kumar and Kalra , 2009) and its usefulness in athlete's cardiac screening 
(Rudski et al., 2010; Lang et al., 2015; D’Ascenzi et al., 2017; Pelliccia et al., 2017) 
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2.2.1.3 Speckle Tracking Echocardiography (STE) 
STE was introduced in 1991 (O’Donnell et al., 1994). It is based on the tracking of 
characteristic speckle patterns generated by destructive and constructive interference of 
ultrasound waves reflected from tissue structures (Amundsen et al., 2006; Geyer et al., 
2010; Mor-Avi et al., 2011). This technique involves using a speckle tracking algorithm 
usually radio frequency based in order to record the uniform motion of a speckle 
producing objects (kernel) (Rappaport et al., 2006). STE is an offline and partly angle 
independent technique that can assess radial, circumferential and longitudinal 
deformation of the myocardium as well as providing a measure of lagrangian ε that can 
be applied to previously acquired 2D images files (Andersen et al., 2004; Geyer et al., 
2010). Therefore, this technique provide a valuable information on measuring of tissue 
deformation and its change in length normalized to the original length (i.e. strain) and 
its rate of strain (SR) (see Figure 2.4). This technique has recently been applied to the 
RV and can assess longitudinal function only (Mor-Avi et al., 2011; Sengupta and 
Narula, 2013; La Gerche and Roberts, 2015b). Previous studies reported measurement 
of RV global and regional ε and SR data are feasible, comparable and reliable at rest 
(Bleeker et al., 2006; Kothari and Ramakrishnan, 2011; Oxborough et al., 2012a; Lord 
et al., 2014). Numerous clinical applications has been implemented in clinic providing a 
prognostic valuable information for various disease such as ARVC (Lang et al., 2015) 
and in sport cardiac screening studies (Oxborough et al., 2012b; Oxborough et al., 2016; 
D’Ascenzi et al., 2017b). 
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2.2.2 Electrocardiography 
The electrical activity is the primary stimulus for mechanical function. It promotes 
cardiac muscle contraction which changes chamber and vessel pressure and thus 
generates the force for blood to flow down a pressure gradient. Consequently, blood 
flows and volume changes will occur. 
 
The electrical signals in the heart are transmitted by a highly specialised anatomical 
structure: 1) the Sinoatrial (SA) node, 2) Atrio-Ventricular (AV) node, 3) AV bundle 
(i.e. Bundle of His), 4) right and left bundle branches and purkinjie fibres. This 
electrical signals are causing atrial and ventricular depolarization and repolarization 
which are represented on the ECG as a series of waves: the P wave followed by the 
QRS complex and the T wave (Fang, 2012; Hampton, 2013)  (see Figure 2.7). 
 
Figure 2. 7: ECG Structure (Pappano and Wier, 2012) 
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The 12-lead ECG is able to detect activity from the right side of the heart by providing 
information from the early precordial leads (V1-V3) which lie close to the right side of 
the heart expressing mainly the electrical conductivity of the RA and the RV. In 
addition, RA enlargement, RV hypertrophy, right sided axis deviation and RV 
repolarisation abnormalities can be detected.  
 
Based on these non-invasive developments it is clear that both echocardiography and 
the 12-lead ECG can provide insight into RV structure, function and electrical integrity. 
It is apparent that the application of both these techniques is important when 
considering the diagnosis of disease or when trying to differentiate physiological from 
pathological adaptation.  
 
2.3 Sudden Cardiac Death (SCD) in athletes: 
SCD in athletes is defined as unexpected death occurring during or after exercise with 
the true incidence remaining uncertain. In Italy, they suggested that SCD is three-times 
higher in athletes compared to non-athletes (Corrado et al., 2003), whilst SCD rates in 
females are recognised to be 2-25 times lower than in men. In addition, the incidence of 
SCD increases with age, being higher in athletes over 35 years old compared to younger 
athletes. Although certain demographics may predispose and athlete to SCD there is not 
a clear correlation between type of sports (Mont et al., 2016).  In the UK, the causes of 
SCD in the athletic population have been summarised in figure 2.8 highlighting relevant 
conditions from the UK registry of young athletes (Finocchiaro et al., 2016). In view of 
this, PPCS is mandatory in many sporting disciplines to identify those athletes at risk of 
SCD.  
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The prevalence of cardiovascular disorders is estimated at 0.3% of the athletic 
population and ARVC is responsible for approximately 4,3% of the cases (Maron, 
2007; Harmon et al., 2015). In addition,  It has been estimated that ARVC is the cause 
of SCD in 4-23% of cases in the athletic population (Chandra et al., 2013; Mont et al., 
2016) (see Figure 2.8) and is the most frequent pathology in Italian studies (Corrado et 
al., 2005). It was demonstrated  to be present in 10% of all sudden cardiac arrest victims 
in France (Nava et al., 1988; Sorrell, Kumar and Kalra , 2009) and most common below 
the age of 40 years (Ferreira et al., 2003; Wang et al., 2010). Accuracy of prevalence 
data is debated due to the complexities in diagnosing the disease and the unexplained 
genotype-phenotype expression.  
 
 
Figure 2. 8: Causes of sudden cardiac death in athletic population: sudden arrhythmic 
death syndrome (SADS), Hypertrophic cardiomyopathy (HCM), Left ventricular 
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hypertrophy (LVH), Arrhythmogenic right ventricular cardiomyopathy (ARVC) and 
Dilated cardiomyopathy (DCM) (adapted from Oxborough et al., 2018)  
  
2.4 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) 
ARVC is a genetic disease of that affects desmosomal dysfunction within the 
cardiomyocyte (Basso et al., 1996) Desmosomes are protein structures in the cell 
membrane premitting cell-to-cell adhesion. They occur in almost all solid tissue, but 
disease related to mutation in these proteins are manifested only in the heart muscle 
cells causing the protein and gap junction to develop a gradual disruption of the 
myocardial cells and to degenerate due to excess mechanical stress/forces which alter 
the biomechanical and biochemical behaviour of cells. As a result of these changes in 
the myocytes the normal myocardium is replaced by fibro fatty scar tissue (Basso et al., 
1996). ARVC will cause global cellular disruption and atrophy of the myocardium and 
can lead to aneurysmal dilation and wall motion abnormalities with end-stage ARVC 
resulting in heart failure and subsequently death (Sen-Chowdhry et al., 2008; Marcus et 
al., 2009). ARVC is a predominantly RV disease, but occasionally it may involve  LV 
myocytes  (Sen-Chowdhry et al., 2008; Basso et al., 2009).  
 
The natural history of ARVC is variable with various clinical presentations. Four 
clinical phases have been proposed: 1) concealed form of structural abnormalities and 
unnoticeable symptoms reported. In this phase, SCD might be the first manifestation 
(Corrado et al., 1997; Tabib et al., 2003; Merner et al., 2008; Sarvari et al., 2011; 
Romero et al., 2013; Gaido et al., 2017) and usually the diagnosis at this stage is based 
on family screening through genetic testing (Romero et al., 2013), 2) overt electrical 
anomalies usually occurs in young patients and are associated with ventricular 
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arrhythmia and SCD, 3) RV failure caused by progressive loss of myocardium with 
severe dilation and systolic dysfunction with pump failure (Sarvari et al., 2011; Romero 
et al., 2013; Gaido et al., 2017) and 4) biventricular failure described as the late and 
progressive phase of the ARVC disease. Importantly, it has been suggested that the 
existence of life-threatening arrhythmia or electrical changes can precede structural 
changes (Marcus et al., 2010; Sarvari et al., 2011) or any clinical evidence of myocyte 
loss and RV dysfunction (Gaido et al., 2017). There are however some other studies that 
have reported normal electrical activity in these patients (Bauce et al., 2010; Marcus et 
al., 2010; Zaidi et al., 2013b), exacerbating the diagnostic challenge in this condition.  
 
Currently, the diagnosis of ARVC is established in accordance with the revised TFC 
(Marcus et al., 2010). It involves a multivariant model and tools from ECG, 
echocardiography, cMRI, tissue characterisation and family history. These categories 
contain major and minor criteria and include global and/or regional dysfunction and 
structural alterations, tissue characterisation of the wall, repolarisation abnormalities, 
depolarisation/conduction abnormalities, arrhythmias and an adverse family history. 
Based on TFC, it is required that 2 major criteria or 1 major criteria and 2 minor criteria 
or 4 minor criteria from different categories in order to give a definitive ARVC 
diagnosis (see Table 2.1). Consequently, various types of evaluation should be 
conducted for diagnosing ARVC, especially when a patient has a suspicious physical 
examination and family history.  
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Table 2.1 : Modified Task Force Criteria 2010 (adapted from Marcus et al., 2010) 
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2.4.1 Electrocardiography in ARVC 
The ECG is considered to be one of the most important tools in cardiovascular 
screening for detecting ARVC. The disease is characterized by progressive replacement 
of the myocardium by fibrous and fatty tissue in the free wall of the RV which is the 
final part of the heart to depolarise (Durrer D et al., 1970; Marcus 2009). In this setting, 
when there is damage to the musculature of the RV free wall, there may be 
fragmentation and selective slowing and prolongation at the end of the QRS complex in 
the anterior precordial leads. The delay in depolarization may be extremely prolonged 
and may be visible as  low frequency, low amplitude waves that extend beyond the QRS 
complex and before the T wave; known as epsilon waves (Fontaine et al., 1978; Marcus 
2009). In addition, T wave inversion is often a manifestation of myocardial injury such 
as in patients with an anterior myocardial infarction, Likewise, this is an ECG feature in 
patients with ARVC where the RV free wall musculature has been replaced by fibrous-
fatty tissue (Marcus 1986, 2009). 
 
In this condition, T-wave inversion (TWI) in the anterior leads (in the absence of right 
bundle branch block) has been reported to have a sensitivity of up to 81% (Nava et al., 
2000; Marcus et al., 2009), with a specificity of 97% in young adults without the 
disease (Marcus, 2005). The presence of a combination of both TWI and ectopic 
ventricular beats of RV origin increases the likelihood of making a diagnosis of ARVC. 
In the absence of right bundle branch block (RBBB), up to 76% of ARVC cases 
presented with prolongation of conduction and depolarisation of the QRS complex 
exceeding 110ms in V1-V3 (Nasir et al., 2004; Piccini et al., 2005). Also, up to 71% of 
ARVC cases were presented with prolongation of the S-wave duration (Peters et al., 
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2007). The most distinct feature of ARVC disease on ECG is the presence with epsilon 
wave which is considered to be a major criteria but it is present in only 30% of cases 
(Hurst, 1998; Biernacka et al., 2017). That aside, even in marked structural / functional 
phenotypes of the disease there may still be the presence of a normal ECG (Marcus et 
al., 2010; Zaidi et al., 2013b). In addition, ECG sensitivity for detection in the 
concealed phase of the disease is poor (Sorrell, Kumar and Kalra, 2009). 
 
Furthermore, A positive signal average electrocardiogram (SAECG) is another minor 
TFC for ARVC diagnosis. The test involves the use of special ECG equipment to 
markedly increase the amplitude of the QRS complex in order to accurately measure the 
duration of the QRS complex as well as to observe and measure the small electrical 
potentials that may occur after the end of the QRS complex (Marcus et al., 2010) (see 
Table 2.1). 
 
2.4.2 Echocardiography in ARVC 
In view of this, the echocardiogram has been shown to provide added value for the 
diagnosis of ARVC (Marcus et al., 2009). Although, the 2010 Task Force revision has 
improved specificity of the technique it appears to have had less impact upon diagnostic 
sensitivity (Vitarelli et al., 2013). The possible explanation for this is based on the 
dependence on two RV anatomical measures (i.e. RV outflow tract from a parasternal 
long [RVOT-PLAX] and short axis [RVOT1] or [RVOT-SAX] and one functional 
measure (i.e. RVFAC). RV structure and function are complex and therefore it is 
pertinent to speculate that in order to increase its diagnostic sensitivity specifically in 
ARVC where phenotype expression is variable (Sorrell, Kumar and Kalra , 2009; Aneq 
et al., 2012) a more substantive assessment of RV structure and function is required. 
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Therefore, it is necessary to develop a more comprehensive echocardiographic 
assessment (Zaidi et al., 2015) to improve the diagnostic accuracy whilst conforming to 
standardised guidelines (Lang et al., 2015; Wharton et al., 2015) 
 
2.5 Pre-participation cardiac screening (PPCS) of Competitive Athletes 
PPCS is employed within the athletic population to identify those individuals who may 
be predisposed to SCD through an inherited cardiac condition such as ARVC. Italian 
data from Corrado et al., (2006) presented an 89% reduction in the annual incidence of 
SCD in screened athletes compared to an unscreened non-athlete population (Corrado et 
al., 2006) (see Figure 2.9). That aside, Van Brabandt et al., (2016) suggest that this 
study should be interpreted with caution, as it fails to prove that the reduction in SCD 
could be attributed directly to pre-participation screening (Van Brabandt et al., 2016).  
In addition, Corrado et al 2009 did not utilise a randomised study design with an 
unscreened control group to further justify the effectiveness of cardiac screening. It 
could also be argued that a randomised study design was not feasible due to the ethical 
implications as screening is compulsory by law in Italy (Corrado et al., 2016). However, 
despite the critique around Corrado et al. 2009 study and its figure 2.9, a recent study by 
Malhotra et al, (2018) screened 11,168 adolescent athletes From 1996 through 2016 in 
the English Football Association (FA) and stated that deaths are three times greater than 
expected and up to 70% players with serious diseases can be tested which raising 
awareness of the importance of routine cardiac screening to save young lives (Malhotra 
et al, 2018) and thus demonstrates the importance of PPCS.  
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Figure 2. 9: Annual incidence rates of sudden cardiovascular death among screened 
competitive athletes and unscreened non-athletes 12–35 years of age in the Veneto 
Region of Italy, from 1979 to 2004 (adapted from Corrado et al., 2011) 
 
The application of specific criteria for 12-lead ECG interpretation during PPCS has 
been shown to reduce abnormal ECGs and false positives results and consequently the 
ration of athletes excluded per life saved is likely to be high (Sheikh et al., 2014; 
Kumar, Kalman and La Gerche, 2017; Drezner et al., 2017; Sharma et al., 2017). The 
PPCS utilises a range of investigations (see Figure 2.10). 
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Figure 2. 10: Flow diagram illustrating the modality of pre-participation cardiovascular 
screening recommended by the European Society of Cardiology section of Sports 
Cardiology (adapted from Corrado et al., 2011) 
 
PPCS is recommended by both the American Heart Association and the European 
Society of Cardiology. In the United States of America, only a family history and a 
physical examination is recommended, whereas in Europe a 12-lead ECG is mandatory 
(Grazioli et al., 2014). Different countries also within Europe apply different regulation 
regarding the methods of PPCS and there are a number of sporting organisations that 
advocate echocardiography as a primary investigation (Corrado et al., 2011; Mont et al., 
2016).  
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Specific sporting/screening organisation also will decide whether athletes require a 
routine transthoracic echocardiogram (TTE) as a first line investigation within the 
standard screening protocol (Mont et al., 2016; Oxborough et al., 2018) (see Table 2.2). 
 
Table 2.2: Major international sporting federations with a pre-participation 
cardiovascular screening policy for elite or professional athletes (adapted from Mont et 
al., 2016) 
Sporting 
Federation 
Mandatory 
or 
recommen
ded 
Screening 
protocoScree
ning protocol 
Primary screening methodology 
Physica
l 
examin
ation 
Personal 
symptom 
and FH 
12-
lead 
ECG 
Echoc
ardiog
raphy 
International 
Olympic 
Committee 
Recomme
nd 
IOC ✓ ✓ ✓ 
 
International 
Paralympic 
Committee 
Recomme
nd 
IOC ✓ ✓ ✓ 
 
Fédération 
Internationale de 
Football 
Association 
Mandate Self-imposed ✓ ✓ ✓ ✓ 
Union of 
European Football 
Associations 
Mandate Self-imposed ✓ ✓ ✓ ✓ 
Union Cycliste 
Internationale 
Mandate Self-imposed ✓ ✓ ✓ ✓ 
Fédératoin 
Internationale de 
Motocyclisme 
Mandate Self-imposed ✓ ✓ ✓ ✓ 
Fédération 
Internationale de 
l'Automobile 
Mandate Self-imposed ✓ ✓ ✓ ✓ 
International 
Association of 
Athletic 
Federations 
Recomme
nd 
IOC ✓ ✓ ✓ 
 
National 
Basketball 
Association (USA) 
Recomme
nd 
AHA ✓ ✓ ✓ 
 
National Football 
League (USA) 
Recomme
nd 
AHA ✓ ✓ 
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Major League 
Baseball (USA) 
Recomme
nd 
AHA ✓ ✓ 
  
National Hockey 
League (USA) 
Recomme
nd 
AHA ✓ ✓ 
  
World Rugby 
Recomme
nd 
Self-imposed ✓ ✓ ✓ 
 
Fédération 
Internationale de 
Natation 
Recomme
nd 
Self-imposed ✓ ✓ ✓ 
 
World Boxing 
Federation 
Recomme
nd 
Self-imposed ✓ ✓ ✓ 
 
International 
Handball 
Federation 
Recomme
nd 
IOC ✓ ✓ ✓ 
 
International 
Triathlon Union 
Recomme
nd 
IOC ✓ ✓ ✓ 
 
Fédération 
Internationale de 
Ski 
Recomme
nd 
IOC ✓ ✓ ✓ 
 
Fédération 
International des 
Sociétés d'Aviron 
Mandate IOC ✓ ✓ ✓ 
 
 
2.6 Athlete's Heart 
In order to accurately differentiate AH from ARVC, it is important to understand 
normal physiological adaptation in RV structure and function to a regular exercise 
stimulus. With this in mind, the following section provides a critical review of the 
literature pertaining to RV adaptation in the athlete. 
   
2.6.1 Right Ventricle 
The human heart adapts to chronic training due to the high demand for blood flow to the 
body during training. Its structural response manifests through augmented chamber size 
and ventricular walls caused by signalling events in the cardiac myocyte that leads to 
protein synthesis (George et al., 2011). Traditionally, the RV has received less attention 
than the LV, however due to developments in imaging technology and high-profile 
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cardiac events, more recent studies have been driven to further explore RV structure and 
function (Brown et al., 2017). 
 
The RV is an essential component of the cardiovascular system. It is responsible for 
receiving blood from the right atrium and for pumping blood into the pulmonary 
circulation. As the oxygen demand increases during exercise, the RV has to meet this 
demand by supplying an adequate stroke volume through pulmonary system and hence 
RV adaptation is important in providing the athlete with this capacity (George et al., 
2011; Duncan, 2012). Numerous studies have utilised echocardiography to describe RV 
adaptation secondary to various types of exercise training such as strength (static) (i.e. 
as body builders and weightlifters) (D’Andrea et al., 2013; Utomi et al., 2013; 
Oxborough et al., 2016; D’Ascenzi et al., 2017a), endurance (dynamic) (i.e. long-
distance runners, swimmers, and cross-country skiers) (D’Andrea et al., 2013; 
Oxborough et al., 2012b; Utomi et al., 2013; D’Ascenzi et al., 2017a) and combined 
(i.e. rowers, cyclist and speed skaters) (D’Ascenzi et al., 2017b).  Based on this, a recent 
meta-analysis has attempted to provide normal values for 2D echocardiographic indices 
in the assessment of RV structure and function among elite athletes (see Table 2.3- 2.5).
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Table 2. 3: Demographic characteristics of echocardiographic studies assessing RV structure and function in competitive athletes (adapted from 
D'Ascenzi et al. (2017b)) 
First 
author 
Year 
Type of 
sport 
n Gender First author Year Type of sport n Gender 
Douglas 1990 Combined 41 M, F 
Pagourelias 2013 
Mixed 80 
M 
Henriksen 1996 Endurance 127 M Strength 28 
Henriksen 1999 Endurance 42 F Schmied 2013 Endurance 210 M 
Erol 2002 Mixed 36 M Simsek 2013 Endurance 44 M, F 
D’Andrea 2003 
Endurance 32 
M 
Vitarelli 2013 
Endurance 35 
M 
Endurance 26 Strength 35 
Kasikcioglu 2005 Mixed 52 M Strength 35 
Neilan 2006 Endurance 20 M, F 
Zaidi 2013 
Mixed 300 
M, F 
Koc 2007 Mixed 60 M, F Mixed 375 
Baggish 2008 
Combined 20 F Zaidi 2013 Mixed 627 M, F 
Combined 20 M D’Ascenzi 2014 Endurance 24 F 
Combined 24 M Esposito 2014 Combined 40 M 
La Gerche 2008 Combined 27 M, F Gjerdalen 2014 Endurance 553 M 
Poh 2008 Combined 24 M, F 
Leischik 2014 
Combined 54 M 
Teske 2009 Combined 24 M, F Combined 33 F 
Baggish 2010 
Mixed 58 
M, F Giraldeau 2015 
Mixed 45 M 
Mixed 63 Mixed 45 F 
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Mixed 54 Grunig 
 
2015 
Endurance 395 
M, F 
Bauce 2010 Endurance 40 M, F Strength 255 
D’Andrea 2010 Endurance 50 M Hedman 2015 Mixed 46 F 
D’Andrea 2011 
Endurance 370 
M, F 
Jongman 2015 Combined 24 M 
Strength 245 Major 2015 Mixed 52 M 
Krol 2011 Combined 38 M, F Malmgren 2015 Endurance 33 F 
La Gerche 2011 Endurance 39 M, F 
Utomi 2015 
Endurance 19 
M 
Popovic 2011 
Combined 21 
M 
Strength 21 
Strength 16 D’Ascenzi 2016 Endurance 35 M, F 
D’Andrea 2012 
Endurance 220 
M, F 
D’Ascenzi 2016 Endurance 29 M, F 
Strength 210 
D’Ascenzi 2017 
Mixed 262 
M, F 
Karlstedt 2012 Endurance 25 M, F Strength 277 
Oxborough 2012 Mixed 102 M, F Mixed 216 
Bernheim 2013 Combined 38 M, F Mixed 254 
D’Ascenzi 2013 Endurance 100 M, F 
 
King 2013 
Combined 18 
M 
Endurance 24 
Moro 2013 
Endurance 17 
M Endurance 19 
Endurance 21 
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Table 2. 4: Suggested normal values for 2D echocardiogc parameters of RV structure in male competitve athletes (Data are mean (95% CI) (adapted 
from D'Ascenzi et al. (2017b)) 
RVOT-PLAX (mm)  RV end-systolic area (cm2)  
Endurance 29 (26-33) Endurance 13 (10-15) 
Combined 29 (26-33) Combined 17 (14-20) 
Mixed 29 (26-33) Mixed 13 (8-18) 
Strength 29 (26-33) Strength 10 (8-13) 
RVOT-PLAX index (mm/m2)  RV end-systolic area index (cm2/m2)  
Endurance 17 (15-18) Endurance 9 (7-10) 
Combined 17 (15-18) Combined 9 (7-10) 
Mixed 17 (15-18) Mixed 9 (7-10) 
Strength 17 (15-18) Strength 9 (7-10) 
RVOT1 (mm)  RV basal diameter (mm)  
Endurance 34 (32-35) Endurance 40 (38-42) 
Combined 34 (32-35) Combined 44 (39-49) 
Mixed 34 (32-35) Mixed 43 (41-44) 
Strength 34 (32-35) Strength 38 (31-45) 
RVOT1 index (mm/m
2
)  RV basal diameter index (mm/m
2
)  
Endurance 18 (16-20) Endurance 23 (19-26) 
Combined 18 (16-20) Combined 23 (19-26) 
Mixed 18 (16-20) Mixed 23 (19-26) 
Strength 18 (16-20) Strength 23 (19-26) 
RVOT distal diameter (mm)      RV midcavity diameter (mm)  
Endurance 31 (27-34) Endurance 29 (27-30) 
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Combined 31 (27-34) Combined 41 (37-46) 
Mixed 31 (27-34) Mixed 36 (35-37) 
Strength 31 (27-34) Strength 26 (23-29) 
RVOT distal diameter index (mm/m2)  RV midcavity diameter index (mm/m2)  
Endurance 16 (15-18) Endurance 18 (14-22) 
Combined 16 (15-18) Combined 18 (14-22) 
Mixed 16 (15-18) Mixed 18 (14-22) 
Strength 16 (15-18) Strength 18 (14-22) 
RV end-diastolic area (cm2)  RV wall thickness (mm)  
Endurance 23 (20-27) Endurance 4.2 (3.9-4.4) 
Combined 32 (29-35) Combined 7.0 (5-8) 
Mixed 30 (28-31) Mixed nd 
Strength 21 (17-25) Strength 4.0 (3-5) 
RV end-diastolic area index (cm2/m2)    
  
  
Endurance 15 (14-16) 
Combined 15 (14-16) 
Mixed 15 (14-16) 
Strength 15 (14-16) 
RV outflow tract (RVOT) diameter at the parasternal long-axis view (RVOT-PLAX), RV outflow tract diameter at the subpulmonary region (RVOT1) 
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Table 2. 5: Suggested normal values for 2D echocardiogc parameters of RV function in 
male competitve athletes (Data are mean (95% CI) (adapted from D'Ascenzi et al. 
(2017b)) 
RV FAC (%)  
Endurance 35 (32-38) 
Combined 36 (32-40) 
Mixed 43 (36-51) 
Strength 41 (32-49) 
TAPSE (mm)  
Endurance 25 (22-28) 
Combined 25 (22-28) 
Mixed 25 (22-28) 
Strength 25 (22-28) 
TDI s’ velocity (m/sec)  
Endurance 0.17 (0.13-0.20) 
Combined 0.11 (0.09-0.13) 
Mixed 0.14 (0.10-0.19) 
Strength 0.17 (0.13-0.22) 
     TDI e’ velocity (m/sec)  
Endurance 0.18 (0.14-0.22) 
Combined 0.12 (0.10-0.14) 
Mixed 0.16 (0.12-0.20) 
Strength 0.18 (0.16-0.20) 
Strain (%) 
Endurance —24.7 (22.9-26.4) 
Combined —24.7 (22.9-26.4) 
Mixed —24.7 (22.9-26.4) 
Strength —24.7 (22.9-26.4) 
Tricuspid Annular Plane Systolic Excursion (TAPSE), RV Fractional Area Change 
(RVFAC), Peak systolic motion on Tissue Doppler Image (TDI RV S')‏ , early diastolic 
motion (TDI RV E')‏ ,  
 
It has been reported that there is no difference in RV dimension between resistance (i.e. 
static) athletes and sedentary healthy control group (D’Andrea et al., 2013). Endurance 
athletes however, have demonstrated an increased RV inflow and outflow tract 
dimensions compared to resistance (i.e. static) athletes group (D’Andrea et al., 2013; 
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Oxborough et al., 2016). Oxborough et al (2012) also demonstrated that endurance 
athletes have larger RV dimensions at the RV outflow tract (RVOT) and RV inflow 
tract exceeded normal cut-off values (57% and 40%, respectively) (Oxborough et al., 
2012b). The primary stimulus for this adaptation is speculative with La Gerche and 
Claessen (2015a) documenting the effects of increased wall stress (La Gerche and 
Claessen, 2015a) whilst others demonstrating the importance of an increased preload 
(Duncan, 2012). The concept that the RV adapts in response to a disproportionate wall 
stress (afterload) suggesting that during exercise a greater stroke work load and 
pulmonary artery pressure will be placed on the RV (La Gerche and Heidbu, 2011) 
leading to a coping mechanism that elevating the RV contractility and wall stress to 
overcome this afterload at least for a while (D’Andrea et al., 2015). However, the RV 
myocardium is unable to sustain exercise duration for prolonged period of time due to 
its characteristic of having thin wall so a reduction in its contractility occurs followed 
by a reduction in the RV stroke volume (Oxborough et al., 2010; La Gerche et al., 2010; 
Elliot and La Gerche, 2014), subsequently impacting on LV filling (Oxborough et al., 
2010; La Gerche et al., 2010). Oxborough et al., (2011) and La Gerche et al., (2012b) 
reported RV dilation and reduced RV ε and SV with reduction in LV end diastolic 
volume,  LV filling and LV preload in prolonged endurance exercise (Oxborough et al., 
2011; La Gerche et al., 2012b). In support of this, Oxborough et al., (2012) 
demonstrated an increased RV/LV ratio consistent with alternative mechanisms of 
adaptation (Oxborough et al., 2012b). In agreement with this, other studies reported 
increased RV cavity dimension in endurance athletes after completing 6 months 
(Spence et al., 2013; Arbab-Zadeh et al., 2014) and after 12 months associated with an 
elevated RV/LV ratio (Arbab-Zadeh et al., 2014). Different cardiac physiological 
adaptation to training depends on the various factors and is summarized in Figure 2.11.
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Figure 2. 11: The multifactorial impact of cardiac adaptation in the athletes (adapted from Brown et al., 2017)
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The Mitchells classification serves as a guide to the relative dynamic and static 
components to specific sporting disciplines (Mitchell et al., 2005; Levine et al., 2015). 
Dynamic exercise training is defined as low (<50% maximal oxygen uptake (maxO2)), 
moderate (50-75% maximal oxygen uptake (maxO2)) and high (>75% maximal oxygen 
uptake (maxO2)). Static exercise training is classified to low (<10% maximal voluntary 
contraction (MVC) that defined as the greatest amount of tension the relevant muscle 
(groups) can generate and hold), moderate (10-20% MVC) and high (>30% MVC) 
(Levine et al. 2015). Nevertheless, the majority of sports have a combination of both 
dynamic and static due to that cardiac adaptations determined by the degree of 
combination of intensity, duration and frequency induced by individual sports and 
exercise training (Beaudry et al., 2016; Beaumont et al., 2016; Brown et al., 
2017).Therefore, Mitchells classification classified sporting disciplines into 9 groups 
providing information on varies sporting disciplines relative to the static and dynamic 
components which serve as a useful guide in this regard (Mitchell et al., 2005; Levine et 
al., 2015; Oxborough et al., 2018)  (Figure 2. 12). However, many researchers have 
questioned this classification which is based on sport disciplines and not on athletes' 
fitness level related to their underlying training load (intensity and duration). It has been 
well established that there is a strong association between cardiac structure and function 
with exercise training and not sport discipline (Beaudry et al., 2016; Haykowsky et al., 
2018). Although fitness level is important, the Mitchell classification is considered an 
important contribution to the medical field with healthcare professionals utilising it to 
decide whether cardiac patients can participate in sport. 
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Figure 2. 12: Mitchells classification (adapted from Levine et al., 2015) 
 
In a recent meta-analysis, athletes were classified into four categories: 1) strength (i.e. 
bodybuilder), 2) endurance (i.e. long distance runners, swimmers), 3) combined (i.e. 
rowers, cyclist) and 4) mixed (i.e. groups of athletes of different sports classification) 
(D’Ascenzi et al., 2017b). There was no difference in RVOT dimension between the 
four groups, however, the combined group, (which by definition includes high dynamic 
exercise training), demonstrated the greatest RV dimension and RV inflow tract 
(D’Ascenzi et al., 2017b). In support, a study comparing 92 male athletes from mixed 
sport disciplines and were split into groups according to the Mitchells Classification 
demonstrating that the high static and high dynamic group had larger RVOT and RV 
inflow tract compared to the high static and lower dynamic group. These studies 
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demonstrated that dynamic exercise training is the primary motivator for RV adaption 
(Oxborough et al., 2016). However, more work needed to be done exploring the 
influence of different dynamic component levels only based on Mitchells Classification 
on RV morphology and function by utilising novel echocardiography technique with 
myocardial regional assessment.   
 
Right ventricular mechanics are unique due to the predominance of longitudinal fibres 
in a thin walled chamber and thus there is significant contribution of longitudinal ε to 
RV SV (Kukulski et al., 2000; Pellerin et al., 2003; Rudski et al., 2010). RV ε is 
heterogenously dispersed compared to the LV (Weidemann et al., 2002). RV ε shows a 
reverse base to apex gradient reaching the highest values in the outflow tract and apical 
segments (Teske et al., 2009b; Mor-Avi et al., 2011) which has been attributed to the 
RV structure and geometry i.e. the thin walled crescent shape and less homogenously 
distribution of regional wall stress (Rudski et al., 2010; Mor-Avi et al., 2011). A study 
by Oxborough et al., (2012b) reported normal longitudinal RV ε value in endurance 
athletes, but Teske et al., (2009b) reported lower values of global longitudinal RV ε in 
elite endurance athletes as well as lower basal regional ε  compared to non-athletes and 
controls group. This reduction in the basal region has been explained by different 
curvature shape that RV apex and basis take in order to control the wall stress during 
exercise. In addition, RV dilation occurrence as a result of exercise primarily involves 
both the RV basal (inflow tract) to lesser extent the outflow tract (Bauce et al., 2010). 
La Gerche et al., (2012a) also explained this reduction due to that the volume is greatest 
at the RV base so a lesser degree of deformation needed to generate the same amount of 
stroke volume. 
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Furthermore, Pagourelias et al., (2013) stated no association between RV size and RV 
function impairment. Previous studies demonstrated a preserved global longitudinal RV 
ε in highly trained athletes (Oxborough et al. 2016; D’Andrea et al. 2013; Brown et al. 
2017) providing evidence that function at rest remains within the normal range in 
athletes, regardless of sport discipline, training volume and morphological remodelling. 
 
In clinical bases, RV ε imaging has demonstrated the fundamental ability to identify 
regional wall motion abnormalities in ARVC patients (Teske et al., 2009a) and in 
asymptomatic ARVC patient mutations carriers (Teske et al., 2012). Therefore, the 
ability to quantify regional RV dysfunction objectively by STE may increase the 
sensitivity to distinguish between physiological adaptation and pathology such as 
ARVC. 
 
2.6.2 12-lead ECG in athletes 
Chronic exercise training is usually associated with unique electrical presentation on the 
ECG that reflects on the cardiac changes in its nervous system and chambers size and 
that makes the differential diagnosis from ARVC in athletes more complicated. 
Therefore,  an international group of experts in sports cardiology presented a list of 
normal, borderline and abnormal ECG finding that does or does not need further 
investigation if athletes presented with one of these criteria (Drezner et al., 2017; 
Sharma et al., 2017) (see Figure 2.13 ).  
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Figure 2. 13: International consensus standards for ECG interpretation in athletes 
(adapted from Drezner et al. 2017) 
 
Chronic exercise training is usually associated with unique electrical presentation on the 
ECG that reflects on the cardiac changes in its increased vagal tone including: 1) early 
repolarisation, 2) sinus bradycardia, 3) sinus arrthymia, 4) ectopic atrial rhythm, 5)1
st
 
degree atrioventricular (AV) block and 6) Mobitz type I 2nd degree AV block, that 
considerd to be normal ECG finding related to exercise training (Drezner et al., 2017; 
Sharma et al., 2017). Besides, regular long-term exercise training is also associated with 
increased RV chamber size causing physiological increase in cardiac mass from athletic 
cardiac remodelling presented by voltage criteria for left venticular hypertrophy and for 
right ventricular hypertrophy (RVH), incomplete RBBB (Drezner et al., 2017; Sharma 
et al., 2017). 
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Many factors can affect the QRS voltage criteria such as gender, sex and age (Drezner 
et al., 2017). Elite athletes often persuade QRS voltage criteria with up to 13% for RVH 
of athletes meeting the Sokolow-Lyon index. RVH and incomplete RBBB used to 
reflect the increase in RV size from athletic cardiac remodelling, but, in a study carried 
out by Zaidi et al., (2013) consisted of 627 athletes and 68 patient with ARVC  
demonstrated that athletes might present with isolated QRS voltages for RVH without 
correlating with underlying pathology and also none of the athletes with isolated QRS 
voltage criteria for RVH had any RV pathology on cMRI. They also reported that none 
of the ARVC patients present voltage criteria for RVH in the absence of additional ECG 
abnormality. In addition, RVH showed to have poor correlation with increased RV wall 
thickness on echocardiography (Zaidi et al., 2013b). Apart from QRS voltage criteria 
for RVH, Kim et al., (2011) stated in their study, which consisted of 510 athletes, that 
incomplete RBBB in athletes considered to be normal physiological adaptation to 
exercise in which the mildly delayed RV conduction, which is measured by QRS 
duration is caused by RV remodelling associated with augmented RV cavity size and 
thus increase its electrical conduction time instead than being an intrinsic delay within 
the HIS-Purkinjie system (Kim et al., 2011). Therefore, RVH by voltage criteria appears 
to be a benign phenomenon among male elite athletes unless it associated additional 
abnormal ECG finding such as TWI and/or right-axis deviation (i.e. borderline criteria) 
to elicit further investigation.  
  
Athletes may exhibit abnormal ECG finding that mimic those documented in ARVC 
such as T-wave inversion (TWI). Although, the presence of TWI in ARVC patients is 
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well demonstrated, Brosnan et al., (2014) compared in their study between 1010 non-
endurance athletes and 251 endurance athletes and reported that TWI in anterior lead 
were more common in endurance athletes than non-endurance athletes (1.1 vs 4.0%, 
P<0.0001) (Brosnan et al., 2014). Higher TWI in the anterior leads were presented in 
elite athletes (27%) and lower compared with mixed sport cohort endurance athletes 
(10%) and in other heterogeneous athletes group (2-5%). In a study involving 2958 
athletes aged 16-35 years, a prevalence of 2.3% with TWI in anterior leads and 
importantly none of them were diagnosed with RV pathology (Malhotra et al., 2016). 
Based on this, TWI in anterior leads is recognised to be predominant among endurance 
athletes (Brosnan et al., 2014; Wasfy et al., 2014) which also might suggests that TWI 
inversion is presenting for a higher degree of RV remodelling as consequences of the 
high hemodynamic load placed on the RV (Wasfy et al., 2014; Malhotra et al., 2016) 
and thus increase the "grey zone" for differentiating normal RV remodelling from RV 
pathology predominantly in endurance athletes. In addition, TWI in the anterior leads 
V1-V3 is considered to be a normal ECG finding in black athletes and in all athletes 
aged <16 years (Dreazner et al., 2017; Sharma et al., 2017).  
 
Furthermore, athletes may exhibit TWI in the inferior leads. Although TWI in the 
inferior leads is uncommon, its prevalence among Caucasian elite athletes is about 2% 
and it gets higher among black/African athletes about 8-10% (Drezner, 2012). Brosnan 
et al., (2014) reported 0.4% of endurance athletes to have TWI in the inferior leads 
compared with non-endurance athletes 0.2% which was not significantly different 
between both groups (P=0.49). Although, TWI in the inferior leads is uncommon, its 
existence alone does not indicate RV cardiomyopathy and also it cannot attribute to 
physiological remodelling (Drezner et al., 2017) and thus further studies are needed.  
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In view of this, ECG and echocardiography play pivotal roles in the diagnosis or 
exclusion of inherited cardiac diseases like ARVC with any missed diagnosis having 
serious implications for the athlete (Marcus et al., 2010; Drezner et al., 2017).  
 
2.7 Summary  
It is clear even from the limited databases that physiological adaptation in RV 
morphology may mimic the pathological changes observed in ARVC, which makes the 
differentiation of physiological and pathological remodelling a diagnostic challenge. 
Besides, the specificity of the TFC for diagnosis of ARVC (Marcus et al., 2010) is only 
applicable to the general population and sensitivity reduces significantly when dilatation 
and a reduction in regional contractility occur as a physiological consequence of 
exercise training (Teske et al., 2009b). RV dilatation in endurance trained athletes (i.e. 
high dynamic) met TFC for the diagnosis of ARVC in 40% of elite athletes in absolute 
terms and 6% when accounting for body size (Oxborough et al., 2012b). The evidence 
base describing the RV function in the athletic population is equivocal with some 
studies demonstrating normal RV systolic function (Oxborough et al., 2012b; D’Andrea 
et al., 2013) and others highlighting regional dysfunction at rest (Teske et al., 2009b; La 
Gerche et al., 2012a). A false positive diagnosis of ARVC has the prospect of severe 
consequences, where the removal from competition is mandatory, and brings about 
associated psychological, social, and physical consequences (Rawlins et al., 2009) as 
well as being associated with significant direct and indirect health care costs (Sorrell, 
Kumar and Kalra , 2009).  
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The development in medical technology has improved and helped researchers and 
scientists to shed light on a lot of fields. On particular interest, the development in 
echocardiography and its new mode of imaging have evolved the understanding of the 
cardiovascular system and on the cardiac structure and function. New and novel 
echocardiographic tools, such as myocardial ε studies, may well provide more insight 
into the differences between the AH and ARVC (Teske et al., 2009a; D’Andrea et al., 
2010).  In addition, the physiological nature of cardiac mechanics in the AH is not fully 
understood with only a handful of small studies assessing absolute values (Richand et 
al., 2007; Baggish et al., 2008; D’Andrea et al., 2008) so more studies assessing RV 
structure based on absolute and scaled values and utilising this myocardial ε technique 
will enhance the understanding on RV adaptation to exercise.  
 
Chapter 3- General Methods 
 
 53  
 
Chapter 3- General Methods 
This chapter describes the common methods to the four studies in this thesis and when 
different methods are applied, they are described in the relevant chapters. Initially, the 
chapter starts with preliminary information and then particular attention is paid to 
echocardiographic assessment.  
 
3.1 Preliminary Information 
A prospective cross-sectional study design was performed. Ethics approval for research 
in this thesis was obtained by the Ethics Committee of the Liverpool John Moores 
University. Participant information sheets were provided to all athletes and full written 
informed consent was obtained prior to all data collection. All athletes provided written 
informed consent prior to data collection and cardiac screening. Information pertaining 
to the procedures was discussed prior to any investigation and where appropriate, 
familiarisation of specific measurements and techniques was established (see Appendix 
1- 4).  
 
Athletes attended the echocardiography laboratory for a single visit, ensuring that they 
had not undertaken any exercise training at least 6 hours prior to assessment as previous 
works have highlighted that any transient change in cardiac function is likely to have 
normalised within 6 hours post-recovery (Lord et al., 2015; Lord et al., 2016) and also 
ensuring that they had not consumed alcohol and caffeine for the previous 24 hours. The 
athletes initially completed a personal and family medical history questionnaire and had 
anthropometric assessment of height and weight, measurement of brachial artery blood 
pressure, a 12-lead ECG and a transthoracic echocardiogram performed. Male elite 
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athletes were included if they were; (1) competitive at National level in their specific 
sporting discipline and (2) no personal or early family history of cardiovascular, 
respiratory, renal and/or metabolic disease. Athletes were excluded if; (1) they were 
currently taking prescribed medication and/or (2) had non-training related ECG findings 
upon screening. Athletes were excluded if after the completion of a health 
questionnaire, consultant examination, 12-lead ECG, full echocardiographic 
examination and/or any other clinically relevant follow-up test they had a definitive or 
suggestive diagnosis of cardiovascular disease (Drezner et al., 2017; Sharma et al., 
2017). 
  
3.2 Procedures 
3.2.1 Anthropometric Assessment 
All athletes were assessed for height (HT, m) and body mass (BM, kg) using a standard 
scale and stadiometer (SECA 764, Birmingham, UK). Body surface area (BSA) was 
calculated by using a standardised formula (Mosteller, 1987): 
 
Systolic and diastolic blood pressures were recorded using an automated 
sphygmomanometer (DINAMAP 300, GE Medical System, Milwaukee, Wisconsin, 
USA) after at least 5 minutes of quiet seated rest due to the logistical challenges of 
screening at a club / sports organisation are such that this study were limited to this so 
that this is a limitation in our studies. Diastolic and systolic blood pressure was recorded 
as the average of three successive measurements. 
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3.2.2 12-Lead ECG 
A standard resting 12-lead ECG (CardioExpress SL6, Spacelabs Healthcare, 
Washington US) specifically placed on the chest (leads V1-V6), both forearms and the 
left leg (leads I, II, III, aVF, aVR and aVL) in accordance with the American heart 
Association (Mason, Hancock and Gettes, 2007) and its interpretation in agreement with 
the international criteria for electrocardiographic interpretation in athletes (Drezner et 
al., 2017; Sharma et al., 2017). 
 
3.2.3 Echocardiographic Assessment  
 
Echocardiographic examination was performed using a Vivid Q ultrasound machine 
(GE Healthcare, Horten, Norway) with a 2.5-5 MHz transducer with the subject in the 
left lateral decubitas position (Henry et al., 1980). All acquisitions were made by two 
experienced sonographers using an echocardiography protocol in accordance with the 
American Society of Echocardiography (Rudski et al., 2010; Lang et al., 2015). Offline 
analysis was performed, after storing the images in a raw Digital Imagine and 
Communications in Medicine format and exported, using commercial available 
software (EchoPAC V.110.0.2; GE Helathcare, Horten, Norway). All measurements 
were made in accordance with American Society of Echocardiography guidelines (Lang 
et al., 2015) by the same sonographers.  
 
3.2.3.1 Conventional 2D and Tissue Doppler measures 
Harmonic images were used to perform the M-mode and 2D echocardiography so as to 
make the most of temporal and spatial resolution. This entails the adjustment of various 
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ultrasound parameters such as frame rate, gain, angle width, dynamic range, frequency 
and depth. 2D images were achieved in accordance with the ASE (Lang et al., 2015). 
 
The size of the RV outflow tract dimension was assessed at 3 specific locations. The 
proximal aspect was measured from a parasternal long and short axis orientation 
(RVOT-PLAX and RVOT1, respectively) and the distal level from a parasternal short 
axis view (RVOT2) (see Figure 3). 
 
Figure 3. 1: RV outflow tract diameter at the parasternal long-axis view (RVOT-
PLAX) 
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Figure 3. 2: RV outflow tract diameter at the subpulmonary region (RVOT1 or RVOT-
SAX) 
 
Figure 3. 3: RV outflow tract diameter at the pulmonic valve annulus (RVOT2) 
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The RV inflow was assessed using a modified apical four chamber orientation (Rudski 
et al., 2010), with minor dimensions taken at the basal and mid-levels (RVD1 and 
RVD2 respectively). The RV basal diameter described as the maximal short axis in the 
basal of the RV. RV mid-cavity diameter measured at the mid third of the RV at the LV 
papillary muscle level. RV length was measured from apex to the tricuspid annulus 
(RVD3) (see Figure 3.4).  
 
Figure 3. 4: Basal RV diameter (RVD1), Mid RV diameter (RVD2), Base-to-apex 
length (RVD3) 
 
To establish relative outflow and inflow dimensions the ratio RVOT1/RVD1 was 
calculated. RV area was measured in diastole (RVDA) and systole (RVSA) by tracing 
the RV endocardium using the same modified apical four chamber view and RVFAC 
was calculated by this equation below: (RVFAC (%) = (RVDA – RVSA) / RVDA) (see 
Figure 3.5 and 3.6). 
Chapter 3- General Methods 
 
 59  
 
 
Figure 3. 5: RV end-diastolic area (RVDA) 
 
Figure 3. 6: RV end-systolic area (RVSA) 
 
From a subcostal view, RV wall thickness (RVWT) was measured at mid wall level (see 
Figure 3.7). 
 
Chapter 3- General Methods 
 
 60  
 
 
Figure 3. 7: RV wall thickness (RVWT) 
 
For clinical utility, all structural variables were scaled to individual differences in BSA 
using a standard linear model. That aside, it is well established that biological systems 
follow a non-linear relationship and hence all indices were also scaled allometrically 
according to the laws of geometric similarity. This data provides size independent 
values that allow direct comparison across athletes of different body composition and 
involves scaling linear dimensions to BSA
0.5
 and area measurements directly to BSA 
(Batterham et al., 1999). 
 
RV longitudinal function was assessed using pulsed wave TDI and M-mode derived 
TAPSE of the RV lateral wall. This allowed the derivation of peak myocardial 
velocities in systole (S’), early diastole (E’) and late diastole (A’). Pulsed wave Doppler 
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of the RVOT allowed the assessment of RV velocity time interval (RVOT VTI) (see 
figure 3.8). 
 
 
Figure 3. 8: RV velocity time interval (RVOT VTI) 
 
3.2.3.2 Speckle tracking echocardiography measures 
The modified apical four-chamber view was used for the assessment of longitudinal RV 
lateral wall and septal ε and SR. To provide optimal endocardial delineation, images 
were optimised using depth, gain, compression and sector width. Frame rates were set 
between 80 and 90 frames per second (Artis et al., 2008) and the focal point was 
positioned mid cavity to reduce the impact of beam divergence. For offline analysis, 
pulmonary valve closure (PVC) was obtained from the pulsed wave Doppler signal at 
the RVOT.  A region of interest was placed around the RV basal lateral wall through to 
basal septum encompassing the mid and apical wall segments (see Figure 9).  
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Figure 3. 9: Region of Interest placed down the RV wall 
 
By tracking the continuous frame-by-frame of the ‘natural acoustic market’, the 
myocardial deformation was established (Korinek et al., 2005) and ε were determined 
from the change in length normalised to the original length, while the SR is the rate of 
displacement (Hein and O Brien, 1993). The analysis software comprises of better 
averaging abilities that enhance signal to noise ratio (Modesto et al., 2006) in addition 
to the automatic software grading of the tracking quality the base, mid and apical 
segments and presented an assessment of tracking quality with segments being excluded 
if deemed unacceptable. 
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Regional peak and time to peak RV ε, peak systolic SR (SRS’), peak early diastolic SR 
(SRE') and peak late diastolic SR (SRA') were obtained for each of the 6 myocardial 
segments and a global value was determined as an average of the base, mid and apical 
wall segments. A base to apex ε gradient was calculated for both the septum and the 
lateral wall as the difference between the peak values at both sites (see Figure 3.10 and 
3.11). 
 
 
Figure 3. 10: Longitudinal ε Curves for the RV 
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Figure 3. 11: Longitudinal SR Curves for the RV 
 
In addition to the peak data, the raw data was exported to an excel spreadsheet (Excel, 
Microsoft Corp, Washington, US), where it underwent cubic spline interpolation to 
correct for variations in heart rates (Burns et al., 2010; Stohr et al., 2010) providing 300 
ε and SR points in systole and 300 points in diastole. Normalization was realized by 
transferring the raw data to specialized graph software (San Diego, GraphPad Prism, 
and California). This data was then split into 5% increments to provide a comprehensive 
temporal assessment of RV ε across the cardiac cycle. 
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In order to establish intraobserver variability of blood pressure and conventional and 
strain imaging, the measurements from 10 athletes were repeated and the coefficient of 
variation presented (see tables 3.1 to 3.4). 
 
 Table 3.1: Intra-observer reliability and absolute mean± S.D. values for measurements 
in two times with Coefficient of variations (CoV) for the systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) 
 Scan 1 Scan 2 CoV  (%) 
Systolic blood 
pressure (mmHg) 
132 ± 9 129 ± 12 2 
Diastolic blood 
pressure (mmHg) 
75 ± 6 76 ± 5 2 
 
Table 3. 2: Intra-observer reliability and absolute mean± S.D. values for measurements 
in two times with Coefficient of variations (CoV) for the RV structure 
 Scan 1 Scan 2 CoV (%) 
RVOT-PLAX 
30±4 31±4 4 
RVOT1 
30±3 31±3 7 
RVOT2 (mm) 
26±2 25±2 7 
RVD1 (mm) 
46±6 46±5 6 
RVD2 (mm) 
31±6 33±5 8 
RVD3 (mm) 
91±8 90±8 5 
RVDA (cm
2
) 
31±5 27±4 5 
RVSA (cm
2
) 
17±2 16±2 9 
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Table 3. 3: Intra-observer reliability and absolute mean± S.D. values for measurements 
in two times with Coefficient of variations (CoV) for the RV function and longitudinal ε 
and SR 
 Scan 1 Scan 2 CoV (%) 
TAPSE (mm) 
25±4 26±4 8 
TDI RV S' (cm/s) 
13±2 14±2 9 
TDI RV E' (cm/s) 
16±3 17±2 8 
TDI RV A' (cm/s) 
9±3 9±2 8 
Peak Strain (%) 
-24 ± 3 -23 ± 4 6 
Time to Peak 
Strain (s) 
0.4 ± 0.03 0.4  0.05 2 
Peak SRS' (l/s) 
-1.1 ± 0.1 -1.1 ± 0.2 3 
Peak SRE' (l/s) 
1.6 ± 0.2 1.6 ± 0.4 9 
 
Table 3. 4: Intra-observer reliability and absolute mean± S.D. values for measurements 
in two times with Coefficient of variations (CoV) for the temporal ε from base to apex 
gradient (%) and SR (l/s) 
 
Base to apex ε  
gradient (%) and 
SR (l/s) 
Scan 1  Scan 2 CoV (%) 
 lateral Wall:  
Basal ε  
-24.5 ± 6.1 -26.6 ± 6.4 18 
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Basal SRS'  
-1.5 ± 0.3 -1.8 ± 0.7 17 
Basal SRE'  
2.1 ± 0.6 2.5 ± 1.4 18 
Basal SRA'  
0.9 ± 0.4 1.1 ± 0.3 19 
Mid ε  
-29.3 ± 6.5 -29.5 ± 7.4 8 
Mid SRS'  
-1.4 ± 0.3 -1.4 ± 0.4 10 
Mid SRE'  
1.9 ± 0.7 2.0 ± 0.5 9 
Mid SRA'  
0.9 ± 0.3 0.9 ± 0.4 9 
Apical ε  
-34.0 ± 5.3 -31.7 ± 4.9 19 
Apical SRS'  
-2.1 ± 0.4 -1.7 ± 0.3 20 
Apical SRE'  
2.9 ± 0.7 2.5 ± 0.8 29 
Apical SRA'  
1.4 ± 0.5 1.1 ± 0.6 31 
 Septal Wall:  
Basal ε  
-18.4 ± 2.2 -17.3 ± 3.5 16 
Basal SRS'  
-1.1 ± 0.2 -1.2 ± 0.3 17 
Basal SRE'  
1.4 ± 0.2 1.5 ± 0.2 10 
Basal SRA'  
0.7 ± 0.2 0.6 ± 0.2 22 
Mid ε  
-16.9 ± 3.2 -16.9 ± 3.1 7 
Mid SRS'  
-0.9 ± 0.2 -0.9 ± 0.2 5 
Mid SRE'  
1.4 ± 0.3 1.5 ± 0.2 9 
Mid SRA'  
0.5 ± 0.1 0.5 ± 0.2 17 
Apical ε 
-22.3 ± 2.2 -18.9 ± 6.8 33 
Apical SRS'  
-1.9 ± 0.4 -1.4 ± 0.3 28 
Apical SRE'  
2.5 ± 0.5 2.2 ± 1.7 27 
Apical SRA'  
0.7 ± 0.3 0.6 ± 0.3 30 
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Chapter 4: A Meta-Analysis for the Echocardiographic 
Assessment of Right Ventricular Structure and Function in 
ARVC 
 
This study has been published : 
Qasem, M., Utomi, V., George, K., Somauroo, J., Zaidi, A., Forsythe, L., Bhattacharrya, 
S., Lloyd, G., Rana, B.,  Ring, L., Robinson, S., Senior, R.,  Sheikh N., Sitali, M.,  
Sandoval, J., Steeds, R., Stout, M.,  Willis J. and Oxborough, D.  (2016). A meta-
analysis for the echocardiographic assessment of right ventricular structure and function 
in ARVC. Echo research and practice, 3(3), 95-104. It is available at the following 
address : (https://www.ncbi.nlm.nih.gov/pubmed/27686556) 
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Chapter 5: Influence of Different Dynamic Sporting 
Disciplines on Right Ventricular Structure and Function in 
Elite Male Athletes  
 
This study has been Published : 
Qasem, M., George, K., Somauroo, J.,  Forsythe, L., Brown, B. and  Oxborough, D. 
(2018) Influence of Different Dynamic Sporting Disciplines on Right Ventricular 
Structure and Function in Elite Male Athletes. The International Journal of 
Cardiovascular Imaging, PP:1-8. It is available at the following address: 
(https://www.ncbi.nlm.nih.gov/pubmed/29417374) 
 
 
 
 
  
Chapter 6- Study 3 
 
 70  
 
Chapter 6: Right Ventricular Function in Elite Male Athletes 
Meeting the Structural Echocardiographic Task Force 
Criteria for Arrhythmogenic Right Ventricular 
Cardiomyopathy  
  
This study has been published : 
Qasem, M., George, K., Somauroo, J., Forsythe, L., Brown, B. and Oxborough, D. (2018). 
Right ventricular function in elite male athletes meeting the structural 
echocardiographic task force criteria for arrhythmogenic right ventricular 
cardiomyopathy. Journal of sports sciences 1-7. It is available at the following address : 
(https://www.ncbi.nlm.nih.gov/pubmed/30022711) 
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Chapter 7: Electrocardiographic findings in Elite Male 
Athletes who meet the Structural Echocardiographic Task 
Force Criteria for Arrhythmogenic Right Ventricular 
Cardiomyopathy 
 
This chapter compares ECG data for MTFC group and NMTFC and sought to establish 
if there are any differences and correlations between RV dimensions and the 12-lead 
ECG parameters. 
 
7.1 Introduction 
ARVC is one of the leading causes of sudden SCD in young athletes (Finocchiaro et al., 
2016). Recent guidelines (Mont et al., 2017) for pre-participation cardiac screening 
highlight the importance of the role for the ECG in the diagnosis of this condition with 
specific criteria identified as meeting the TFC (Marcus et al., 2010) (see Table 2.1). 
  
The development of the ARVC phenotype is progressive, often with early electrical 
maladaptation occurring prior to any structural changes (Gaido et al., 2017) . In turn, 
maladaptions may then result in life threatening arrhythmias. The 12-lead ECG can 
detect these changes as either: a prolonged S-wave duration of 55 ms in V1-3; localised 
QRS widening of 110 ms in V1-3; the presence of an epsilon wave (observed in 30% of 
ARVC patients) or the presence of TWI in the anterior leads (observed in 85% of 
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patients) (Perez Diez & Brugada, 2008; Corrado et al., 2009; Marcus et al., 2010; 
Biernacka et al., 2017). (see Figure 7.2) 
 
Figure 7. 1: Epsilon wave (adapted from Corrado et al., 2009) 
 
Figure 7. 2: Prolonged S-wave upstroke and localized QRS widening in V2 (adapted 
from Corrado et al., 2009) 
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Figure 7. 3: T-wave inversion in the anterior leads (adapted from Corrado et al., 2009) 
 
As demonstrated in Chapter 5 and a number of previous studies (Oxborough et al., 
2012b; D’Andrea et al., 2013; Oxborough et al., 2016), physiological RV enlargement 
is a common manifestation of the AH, occurring at both the inflow and outflow 
portions. This adaptation has been documented to meet the structural criteria for ARVC 
and even exceed it in a high proportion of athletes (Maron & Pelliccia, 2006; D’Andrea 
et al., 2010; Utomi et al., 2013; D’Ascenzi et al., 2017a, 2017b). It is well known that 
alongside the structural adaptation of both the right and left sides of the heart, elite  
athletes demonstrate a range of ECG changes (Zaidi et al., 2013a; McClean et al., 2017; 
Drezner et al., 2017). These ECG changes have been described in a range of different 
athlete groups (Drezner et al., 2017; McClean et al., 2017) and consequently, these 
observations have informed the development of International ECG criteria. 
Furthermore, these support diagnostic decision-making in cardiac pre-participation 
screening (Drezner et al., 2017; Sharma et al., 2017).  
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The association between physiological adaptation of the structural and electrical 
components of the RV in the AH are not fully understood. As it is clear that structural 
adaptation of the RV in athletes may “mimic” the ARVC phenotype, it is important to 
ascertain in such athletes what type and degree of ECG adaptation (or abnormality) they 
present with and whether this may also mimic ARVC. It is, therefore, the aim of this 
chapter, to document the ECG patterns in those athletes with augmented RVOT 
dimensions that meet the structural TFC for ARVC compared to those athletes NMTFC.  
This study hypothesizes that those athletes that meet structural TFC will present a 
greater degree of training related ECG changes.  
 
7.2 Methods 
 
7.2.1 Participants 
One hundred and thirty-nine male competitive athletes at national level (mean ± SD: 24 
 1 years) allocated to one of two groups: 1) those MTFC; indexed RVOT (from the 
parasternal long axis view) (RVOT-PLAX ≥ 19 mm/m2) and indexed RVOT (from the 
parasternal short axis view) (RVOT-PSAX ≥ 21 mm/m2] and 2) those athletes that those 
NMTFC.  
 
7.2.2 Study Design and Procedures 
A retrospective cross-sectional study design was undertaken. Twenty-eight athletes met 
RV structural TFC with 111 athletes not meeting TFC and were grouped accordingly. 
Both groups were from mixed ethnicity [MTFC: white=93% and other=7%; NMTFC: 
White=79%, Mixed=6%, Asian=3%, Black=5% and other=7%] and sporting disciplines 
[low dynamic sporting disciplines = 18% and 7%, moderate dynamic sporting 
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disciplines = 7% and 22% and high dynamic sporting disciplines = 75% and 71% for 
MTFC and NMTFC respectively] (Mitchell et al., 2005; Levine et al., 2015). All the 
assessments and procedures were acquired and analysed as described in Chapter 3. 
 
7.2.2.1 12-Lead Electrocardiogram 
A standard resting 12-lead ECG (CardioExpress SL6, Spacelabs Healthcare, 
Washington US) was undertaken in accordance with the American Heart Association 
(AHA) (Mason et al., 2007). Measurements were obtained for the following 
measurements: heart rate (HR), PR interval, QT interval, corrected QT interval 
calculated by the Bazzet formula, QRS duration, R wave axis, P wave axis and T wave 
axis. Isolated QRS voltage criteria for LV hypertrophy (LVH) and RV hypertrophy 
(RVH) were determined manually by using Sokolow-Lyon criteria (LV>35 mV and 
RV>10.5mV). In addition, all ECGs were interpreted using the International Consensus 
Standards for electrocardiographic interpretation in athletes (Drezner et al., 2017; 
Sharma et al., 2017) and described as either a normal or abnormal ECG for an elite 
athlete (see Figure 2.13). 
 
7.2.3 Statistical Analysis 
Statistical analysis was performed using Statistical Package for the Social Sciences 
(SPSS) (version 23.0, Chicago IL, USA). Normal distribution was tested using a 
Kolmogorov-Smirnov test. Analysis between both groups was undertaken using 
independent t-tests, where normal distribution was presented, and Mann-Whitney U 
tests when the distribution was not normal. Two-tailed P<0.05 were set as a significant. 
All continuous ECG parameters were presented as mean ± SD whilst prevalence of 
training and non-training related ECG changes were presented as %. Supplementary  
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analysis included Pearson’s correlation analysis of the association between ECG indices 
and RV structural measures. A standard linear correlation was undertaken to determine 
the relative contribution of each independent parameters (i.e. absolute RVOT-PLAX) on 
the dependent variable (i.e. QRS axis and isolated QRS voltage criteria for RVH). 
 
7.3 Results 
Participants baseline demographic data were presented in Table 7.1. As per group 
selection, RV structural parameters for the RVOT were significant higher in MTFC 
(P<0.05) compared to NMTFC group. 
 
Table 7. 1:ECG participant demographics comparing between athletes meeting 
structural task criteria (MTFC) for ARVC and those athletes not meeting task force 
criteria (NMTFC) (Mean ± SD) 
 
NMTFC 
(n=111) 
MTFC 
(n=28) 
P Value 
Age (years) 23 ± 6 26 ± 6 0.169 
BSA 1.9 ± 0.1 1.8 ± 0.2 0.116 
Systolic blood pressure (mmHg) 123 ± 5 118 ± 11 0.052 
Diastolic blood pressure (mmHg) 69 ± 8 69 ± 8 0.853 
Heart Rate (beats.min
-1
) 51 ± 7 53 ± 9 0.308 
Training (years) 13 ± 5 14 ± 7 0.688 
Training (days per week) 6 ± 1 6 ± 1 0.079 
Training (hours per week) 18 ± 9 20 ± 12 0.291 
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There were no significant differences between MTFC compared to NMTFC (P>0.01) 
for any of the ECG parameters except for P duration, QRS voltage criteria for LVH and 
QRS duration (see table 7.2).  
 
Table 7. 2: ECG parameters  comparing between athletes meeting structural task 
criteria (MTFC) for ARVC and those athletes not meeting task force criteria (NMTFC) 
(Mean ± SD) 
 
NMTFC 
(n=111) 
MTFC 
(n=28) 
P Value 
P Duration (ms) 106 ± 21 96 ± 16 0.033 
PR Interval (ms) 173 ± 31 169 ± 29 0.539 
QRS Duration (ms) 93 ± 9 99 ± 16 0.018 
QT Interval (ms) 418 ± 24 419 ± 36 0.848 
QT Corrected (Bazett) 384 ± 23 390 ± 22 0.189 
P Axis 39 ± 28 44 ± 27 0.449 
QRS Axis 66 ± 26 53 ± 52 0.072 
T Axis 37 ± 16 42 ± 14 0.117 
 R wave in V1 + S wave in V5 7 ± 4 7 ± 4 0.727 
 S wave in V1 + R wave in V5 31 ± 10 37 ± 13 0.012 
 
 
85% of MTFC and 83% of NMTFC had normal training related ECG findings (see 
Figure 7.4). 8% of MTFC and 4% NMTFC of athletes was present in a single athlete 
from both groups had abnormal ECG criteria. Anterior TWI in 4% of both MTFC (a 
single athlete) and NMTFC athletes as well as inferior T-wave inversion in a single 
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MTFC athlete (4%). No athletes from both groups presented with any borderline ECG 
finding.  
 
 
Figure 7. 4: Normal Training Related ECG Finding (%): sinus bradycardia (SB); 
ectopic atrial rhythm (EAR); right bundle branch block (RBBB); early repolarisation 
(ER); isolated QRS voltage criteria for LVH without LAD (ECG LVH); isolated QRS 
voltage criteria for RVH without RAD (ECG RVH); sinus arrhythmia (SA) 
 
There was no significant correlations between ECG criteria for RV enlargement (i.e. 
QRS voltage criteria for RVH and RBBB) and absolute RV size structure (P>0.01). 
There was however a significant correlation between QRS axis correlated with absolute 
RVOT-PLAX (r= -0.311 and p= 0.001) accounted for 10% (see Figure 7.5) 
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Figure 7. 5: Scatter Plot of a crroleting between absolute RV outflow tract diameter at 
the parasternal long-axis view (RVOT-PLAX) and ECG QRS 
 
The single athlete presented with abnormal ECG finding i.e. TWI in the inferior leads 
and met the full structural TFC for ARVC, had RVFAC= 42%, TDI RVS'= 16 cm/s and 
RV ε= -25%. The other single health athletes from the same group i.e. MTFC presented 
with TWI in the anterior leads had RVFAC= 44%, TDI RVS'= 12 cm/s and RV ε= -
19%. That aside, the NMTFC has 4 healthy athletes presented with TWI in the anterior 
leads had RVFAC= 59,33,40 and 40%, TDI RVS'= 13, 14,14 and 15 cm/s and RV ε= -
26, -28, -26 and -21%, respectively. 
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7.4 Discussion 
The key findings from this study were: 1) that there were no differences in training and 
non-training ECG findings between MTFC and NMTFC healthy athletes including, 
having TWI in both groups and thus demonstrating a problem with TFC when applying 
it to populations of athletes and; 2) there was no relationship between RV size and those 
ECG indices that are of indicative RV enlargement.  
  
The current study presents normal ECG findings related to exercise training in the 
MTFC athlete’s group and hence there are no significant difference in most of ECG 
parameters when compared to the NMTFC athletes group. Both groups also exhibit an 
approximately similar percentage of normal training related ECG criteria. Chronic 
exercise training is associated with changes in electrical parameters that reflects the 
global effects of training on chamber size as demonstrate by QRS voltage criteria for 
RVH and incomplete RBBB (Drezner et al., 2017). Additionally, this study presents no 
difference in isolated QRS voltage criteria for RVH as well as a lack of any correlation 
with ECG parameter between both groups and thus, supports the findings from previous 
studies (Kim et al., 2011; Zaidi et al., 2013b). In isolation it these changes are 
considered to be normal physiological adaptation of exercise training (Uberoi et al., 
2011; Zaidi et al., 2013b; Drezner et al., 2013). Previous studies (Kim et al., 2011; Zaidi 
et al., 2013b; Drezner et al., 2013) have demonstrated that the presence of incomplete 
RBBB in athletes is considered normal, caused by RV adaptation coupled with 
increased in the RV dimension. 
 
On the other hand, many previous studies (Brosnan et al., 2014; Wasfy et al., 2014; 
Malhotra et al., 2016) have reported TWI in healthy athletes in anterior leads , as well as 
Chapter 7- Study 4 
 81  
 
the  inferior leads (Brosnan et al. 2014). A single healthy athlete from MTFC presented 
with TWI in the inferior leads and another with anterior t-wave inversion without 
systolic dysfunction. These findings in isolation do not suggest  ARVC (Drezner et al., 
2017). In addition to these 2 athletes, 4 athletes in the NMTFC group also presented 
with TWI in the anterior leads highlighting no predominance between groups. Along 
with this, it has been reported TWI in the anterior leads can be a normal finding 
(Brosnan et al., 2014; Wasfy et al., 2014; Malhotra et al., 2016) and is reflective of the 
degree of RV adaptation to exercise (Wasfy et al., 2014; Malhotra et al., 2016). In view 
of this, in contrast to the previous statement that electrical presentation often precedes 
any structural adaptation (Gaido et al., 2017), this study demonstrates that electrical 
changes do not necessarily precede changes in physiological cardiac morphology or 
function and thus is an important issue to be considered during pre-participation 
screening.  
 
7.4.1 Clinical Implication/Perspective 
In pre-participation cardiac screening programs, the differentiation of RV physiological 
adaptation from pathological changes altered by ARVC is of the utmost importance, in 
order to prevent false-positive or false negative screening outcomes. This is crucial for 
preventing SCD or, the unnecessary early retirement from professional sports. 
Consequently, this study provides valuable information on the electrical conduction 
system in athletes meeting structural TFC for ARVC, which may aid in specific 
screening programs. The findings advocate the combination of both ECG with an 
echocardiogram in order to detect the physiological structural RV adaptation.  
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7.4.2 Limitation 
The limitations of this study include the small sample size in the MTFC group, larger 
samples would have improved the power and generalisability of the data. The addition 
of a sedentary control group and ARVC group would also provide some insight. 
Furthermore, this study only investigated RV remodelling among male athletes but, it is 
apparent that further studies in female athletes and/or different ethnicities would be 
valuable. 
 
Additionally, it is well known that highly trained athletes exhibit cardiac adaptation 
including LV hypertrophy (Utomi et al., 2013) and this physiological adaption will 
contribute to changes that occur to the RV through the principle of ventricular 
interdependency (Duncan, 2012). As per design, this study focused only on the RV and 
therefore future studies are needed to assess both ventricular structure and functions as 
determined by echocardiography and 12-lead ECG. 
 
7.5 Conclusion 
Athletes meeting structural TFC for ARVC did not show significant differences on the 
12-lead ECG compared to those athletes NMTFC. These data suggest that training 
related and raining non related and RV ECG indices are independent of physiological 
structural adaptation. In view of this it is apparent that electrical changes do not precede 
changes in RV structure and function in athletes meeting TFC. 
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Chapter 8: General Discussion 
The results of this thesis provide an understanding into the nature of RV structure and 
function pertaining to the AH. In addition, these data will provide information to 
enhance ECG and echocardiography criteria in PPCS for elite male athlete that present 
with extreme phenotypical expression of the AH and meeting TFC for ARVC disease. 
 
8.1 Summary of Findings 
Chapter 4 described the extent and magnitude of conventional echocardiographic and 
STE measures of RV function in patients with ARVC. This evidenced lower cut-off 
values for both RVOT1 and RVDA than the normative cut-off value proposed by ASE, 
and lower than ARVC TFC for RVOT1; thus indicating the potential for a false 
negative result when using the existing criteria in PPCS. In addition, the RVFAC cut-off 
value is higher in this study, than ARVC TFC, which raises another question, of what is 
considered normal. This study demonstrates that additional measures reflect the 
complex geometry and functioning in ARVC, clearly differentiated between ARVC and 
healthy controls. Thus, the finding may provide additional diagnostic and management 
values, especially for PPCS. 
 
Chapter 5 aimed to determine the nature of the impact of the RV phenotype of sporting 
discipline, and its dynamic component, on RV structure and function, as determined by 
conventional echocardiography and STE, in a large sample of elite male athletes. The 
absolute structural measures were reported to be greater in athletes engaged in the 
Moderate dynamic group and High Dynamic training compared to the Low Dynamic 
training group. However, when these absolute measures scaled to the HD training group 
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had the greatest values, when compared to MD and then LD, and even for the RV 
inflow tract (i.e. RVD1). There was no difference in conventional and STE function 
between the three groups. Athletes in the MD training groups, demonstrated smaller 
base to apex ε gradient in both septal and lateral walls, largely due to reduced apical ε 
and this appears to be partly related to absolute RV chamber size.    
 
Chapter 6 and 7 provided additional insight into the AH on those athletes with extreme 
phenotypical presentation of RV dimensions that met for ARVC compared to those not 
meeting TFC. Chapter 6 assessed RV structure and function via echocardiography. By 
design, this study demonstrated greater absolute and scaled RV structural values at 
outflow tract; however, there is a lack of proportional enlargement of the inflow and 
RVDA with an increased RVOT/RVD1 ratio. In addition, functional parameters in this 
study found no differences between both groups for RV FAC and TAPSE with absolute 
RV FAC that met TFC in a small proportion of the athletes. Athletes in the MTFC 
group had lower global RV ε, SRS' and SRA' compared to the NMTFC athletes, which 
may be explained by the larger RVOT dimension. In chapter 7, data was compared 
between both groups via 12-ECG. Results evidenced general normality in the ECG 
findings, and that electrical changes do not necessary precede changes in cardiac 
morphology or function; thus this is an important consideration in PPCS. 
 
8.2 Overarching Issues and Implications for Pre-Participation Screening 
 
8.2.1 Athletes heart adaptation 
In study 2 within this thesis, findings confirmed the importance of the dynamic 
component as a primary factor for cardiac adaptation in a variable population of elite 
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athletes, and its association with. This supporting the concept that chronic dynamic 
training contributes to a ‘bi-ventricle’ hypertrophy of the myocardium (Utomi et al., 
2013). Ventricular enlargement is likely related to the sustained elevation in preload 
experienced during dynamic training that causes a repetitive volume challenge 
(McClean et a., 2014; Oxborough et al., 2016). This enlargement permits an increased 
capacity to meet the high intensity workload through an amplified atrial ejection volume 
to the simultaneously dilating ventricle (Maron et al., 2006). Enlargement may further 
be compounded by increased expression levels of the b-myosin heavy chain isoform 
(fundamental to chamber enlargement) as evidenced from chronic dynamic training 
within animal studies (Hoit et al., 1995). In contrast, structural remodelling was not 
observed in LD athletes. This could be explained by the limited elevation in preload 
during static training, due to its intermittent nature of repetitions with sets and work-to-
rest ratios. Additionally, a Valsalva manoeuvre may be integrated into a static exercise, 
which would have the impact of increasing intra-thoracic pressures and thereby 
concomitantly reducing atrial preload (Haykowsky et al., 2003). Our data suggest that, 
for an athlete to undergo physiological structural remodelling of the ventricle, a chronic 
sustained elevation of preload must be present. Also along with cardiac adaptation, 
exercise in high dynamic training was found to elicit higher inflow and outflow tract 
values, unlike findings reported in an earlier meta-analysis study that reported no 
differences in outflow tract values between different sport disciplines (D’Ascenzi et al., 
2017b). As a result, it is more challenging to differentiate between physiological 
adaptation and RV pathology, such as ARVC in those athletes participating in high 
dynamic exercise training. Importantly, clinical decision-making based on absolute 
cardiac dimension is challenging due to anthropometric differences (Brown et al., 
2017), particularly in bigger athletes as was noted in the MD group. Thus, this study 
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confirms that allometrical scaling to BSA is essential for more effective and accurate 
data interpretation in PCSS.  
 
Furthermore, despite the structural differences in RV structure between different 
dynamic components, there are no general differences in functional parameters; 
conventional, TDI and peak longitudinal RV ε and SR, to support prior studies’ findings 
(D’Andrea et al., 2013; Oxborough et al., 2016). This suggests that long term cardiac 
adaptation occurs primarily at a structural level, providing the same stroke volume 
under different dynamic loads. That aside, Chapter 7 reported general normal ECG 
findings in MTFC with no correlation between RV dimension and ECG, findings that 
are related to RV size (i.e. QRS voltage criteria for RVH and incomplete RBBB). This 
demonstrates that electrical changes do not precede changes in RV structure and 
function in athletes meeting TFC and that echocardiography should be undertaken 
alongside the 12-lead ECG. Also, it is important to state that all participants in the three 
studies in this thesis are healthy athletes therefore more studies are needed to include 
ARVC patients in their data in order to confirm and translate this information into 
clinic.  
 
8.2.2 ARVC and the task force criteria  
ARVC patients tend to have no general RV structural overlap with healthy people as 
demonstrated in Chapter 4. Importantly, there was a lower cut-off value in RVDA 
compared to the ASE recommendations, and lower RVOT1 than ARVC TFC. Thus is 
identifying the potential of raising the false-negative result when using existing criteria, 
especially for those athletes who are involved in high dynamic exercise training. Further 
to this, as has been previously mentioned when exercising, the HD group would 
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increase the RV cavity; inflow and outflow tract, increasing the challenge of diagnosing 
ARVC among athletes. Chapter 6 in this thesis evidenced that even in healthy athletes 
that met structural TFC for ARVC, RV inflow tract and RV end-diastolic area were not 
necessarily greater and that increase the possibility of false-negative and false-positive 
results. Therefore, it is important to understand the local focus on the RVOT may not 
necessarily reflect the overall RV dimension. That aside, RVFAC is considered to be an 
important element and one of the major functional criteria in the TFC for diagnosing 
ARVC. However in Chapter 4, RVFAC reported a higher cut-off value of 42%, 
compared with 33% in the TFC (i.e. 11% difference) and this uncertainty around 
RVFAC continued to arise in athletes in Chapter 5 where healthy athletes in the MTFC 
group exhibited lower RVFAC than proposed by the TFC for RVFAC. Therefore, it is 
suggested that athletes can show a slightly lower RV function at rest as a result of a 
physiological consequences of the extreme RV remodelling, which is induced by 
exercise. Therefore, relying on RVFAC for elite male athletes is not appropriate. Future 
studies are needed therefore, to investigate the effect of chronic exercise on RV function 
via RV FAC and its practicality in cardiac pre-participation screening among elite 
athletes.  
 
The meta-analysis in this thesis reports that additional parameters besides the two RV 
structural and functional parameters recommended by the TFC for ARVC may improve 
the diagnostic ability in PPCS. This is due to the findings of significant differences in 
longitudinal RV ε between ARVC patients and the healthy control group. Further to 
this, chapter 5 presented no significant differences for longitudinal RV ε between 
healthy athletes in different sporting disciplines in different dynamic components. 
Initially, this may present a clinical implication for longitudinal RV ε in diagnosing RV 
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pathology. However, study 3 reported lower longitudinal RV ε in healthy athletes in the 
MTFC groups when compared to NMTFC. Although, this reduction is considered 
small, it is significant in terms of its potential usefulness in differentiating between 
healthy athletes with healthy extreme phenotypical presentations of RV dimensions that 
meet TFC for ARVC and athletes with RV pathology ,however further study needed to 
compare these results to ARVC patients. Along with this, the European Association of 
Cardiovascular Imaging (Pelliccia et al., 2017) recommended the use of the regional RV 
ε as being able to objectively quantify regional RV dysfunction. Despite the regional 
RV ε between MTFC and NMTFC showing no significant difference in the 2nd study 
showing significant difference between MD group compared to both HD and LD groups 
that correlate partly to the BSA. This raise the uncertainty regarding the valuably of 
regional RV ε in PPSC.  
 
In view of this, longitudinal and regional RV ε seems to be influenced by different 
factors, when assessing athletes and consequently, longitudinal and regional ε might not 
appropriate measure for RV in elite athletes in order to differentiate physiological 
adaptation from RV pathology.          
 
8.3 Future Research  
Changes in RV ε may occur in different seasonal variation, and thus, this raises the 
importance of investigating the alteration of RV function in different seasons in PCCS. 
The evidenced strong relationship between training amount (i.e. intensity and duration), 
fitness and cardiac dimension, with the extent of cardiac changes that are 
physiologically appropriate or not, raises questions as to the appropriateness of utilising 
Mitchell Classification without verifying athletes fitness level (Beaudry et al., 2016) 
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that plays important role in determining the time course and pattern of ventricular 
remodelling that related to underlying training load (intensity and duration) and prior 
training exposure (Haykowsky et al., 2018). Moreover, this classification does not 
consider the emotional stress that an athlete experiences during a competitive event, the 
effects of environmental factors, electrolyte abnormalities, or the specific training 
regimen used by the athlete (Mitchell et al., 2005).   
 
Furthermore, few studies from meta-analysis study have examined the LV side in 
ARVC (Prakasa et al, 2007; Bauce et al 2008; Tops et al 2009; Teske et al 2009a; 
Lacoviello et al 2011; Aneq et al 2012). However those available did not offer sufficient 
data to justify inclusion in this study’s data analysis. Notably, researchers have reported 
no difference in LVEF % between ARVC patient and healthy control (Prakasa et al, 
2007; Bauce et al 2008; Tops et al 2009; Lacoviello et al 2011), but this can be 
explained by that the TFC when it established and it was focusing on the RV and 
including only patients without or with mild LV involvement (Marcus et al., 2010). 
Thus it is difficult when using TFC to diagnose ARVC among athletes with LV 
hypertrophy and it is notable that the third study reported significant differences in RV: 
LV ration between MTFC and NMTFC groups, supporting the need for a modified TFC 
for athletes. Future studies should examine also the LV, particularly in athletes with 
hypertrophy.  
 
The studies included in this thesis were cross sectional design as well as meta-analysis of 
male athletes. These methodological designs cannot directly support a ‘cause effect’ 
relationship between exercise, mode and physiological cardiac remodelling. Further work 
should expand the participant base and dataset; to increase the sample size and therefore 
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adequate statistical power, include female subjects as well as a development of a 
prospective cohort design. Another important limitation in our clinical trials is that ECG 
and echocardiography acquisition and post-processing, though performed by experienced 
research scientists, were not blinded to participant identity, therefore the potential for bias 
exists. 
 
8.4 Conclusion  
The nature and extent of the RV adaptation influenced by different dynamic exercise 
training reflects the RV complexity as a result of adaptation to different workloads and 
to provide same stroke volume in different conditions. The normative RV 
echocardiographic structural and functional parameters in ARVC that have been 
presented in this thesis are expected to enhance the efficacy of echocardiography in 
diagnosing ARVC. RVFAC is shown to possess the possibility to go below the range 
that was proposed by the TFC for ARVC in healthy athletes and this demonstrates 
uncertainty when utilised in PPCS. The use of the novel echocardiographic technique is 
evidenced to demonstrate key issues when utilised on athletes in PPCS that needs for 
further investigation before utilising it in PPCS, in differentiating between physiological 
adaptations and ARVC.  
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Appendix 2- Participant Information Sheet 
 
 
 Athlete Information Sheet  
 
Title of Research Study:    
Differentiation of the Athlete's Heart from Cardiomyopathy 
(Heart Muscle Disease)  
 
Principal Investigator:  Dr David Oxborough, Liverpool John Moores University, 
Research Institute for Sport and Exercise Sciences. 
Postgraduate PhD Student Researchers: Mr Mohammad Qasem and Ms Lynsey 
Forsythe, Liverpool John Moores University, Research Institute for Sport and Exercise 
Sciences. 
 
 
Invitation 
 
You are being invited to take part in a collaborative research study between Liverpool 
Heart and Chest Hospital (LHCH) and Liverpool John Moores University (LJMU).  
Before you decide to be a voluntary participant it is important that you understand why 
the research is being done and what it involves. Please take time to read the following 
information. Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide if you want to take part or not. 
 
1. What is the purpose of the study? 
 
The aim of this study is to investigate the structure and function of the heart in athletes 
and in patients with a diagnosed cardiomyopathy in order to understand how best to 
differentiate between increased heart size due to exercise (athletic adaptation) and those 
due to disease (cardiomyopathy). The information obtained from this study may help 
reduce misdiagnosis of athletes during pre-participation cardiac screening.  The results 
may contribute to future cardiac screening guidelines. 
 
2. Why have I been chosen? 
 
You have been invited to take part in this study because you are an elite athlete.  
 
3. Do I have to take part? 
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No. It is up to you to decide whether or not to take part. If you do, you will be asked to 
sign a consent form. You are free to withdraw at any time during and after the 
procedures and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care and the pre-screening 
examination you receive. 
 
4. What will happen to me if I take part? 
 
As a participant in this study, there are no additional costs to you. You will not be paid 
for participating in this study.  The tests that are used in this study will be taken as part 
of your routine pre-participation cardiac screening. This will take place either at your 
sports club / venue or at Liverpool John Moores University. 
 
Initially we will take a measurement of your height and your weight and blood pressure. 
Next you will have a tracing of your heart (a 12-lead electrocardiogram (ECG)). The 
ECG test involves you lying down quietly and it takes approximately 10 minutes. Small 
stickers (which we call electrodes) are placed at strategic points on your chest, arms and 
legs. Flexible leads that extend from the ECG machine are then attached to these 
stickers. The electrical rhythm of your heart is recorded and printed out.  
 
Finally, you will lie down quietly to have an echocardiogram. An echocardiogram is 
very similar to the ultrasound scan that is used for a pregnant woman to check the health 
of her baby. In this study, an echocardiogram will be used to measure the dimensions of 
the heart and the flow of blood in and out of the heart. The echocardiogram will take up 
to 45 minutes. Finally, you will be required to fill in a health questionnaire which will 
take approximately 10 minutes.  
 
The ECG and Echocardiogram are tests to check for problems with your heart. The 
ECG and Echocardiogram tests , and the health questionnaire, that are used in this study 
will be taken as part of your routine pre-participation cardiac screening. The 
experimental part of this work involves the researcher doing further analysis which are 
novel and essentially considered to be the extra element for our research.  All 
investigations in this study will help in defining normal indices for athletes and to 
improve the ability to diagnose any conditions such as a cardiomyopathy. In view of 
this, there is a  very small chance this test will pick up an unexpected finding. Should 
this occur our study cardiologist will contact you to arrange a suitable course of action. 
 
 
5. Are there any benefits/risks involved? 
 
The ECG and echocardiogram will be performed and interpreted by an experienced 
health care professional with expertise in the assessment of cardiac disease. These tests 
are considered standard and will be acquired as part of your cardiac screening regardless 
of whether you choose to participate in this study. In the very unlikely event that an 
unexpected cardiac abnormality is found you will be managed appropriately by the 
overseeing cardiologist.  
 
Data collected may help to inform future pre-participation cardiac screening protocols 
for athletes it may help reduce misdiagnosis of athletes during cardiac screening. 
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There are no expected adverse effects or discomfort from the 12-lead ECG or 
echocardiogram. 
 
6. Will my taking part in the study be kept confidential? 
 
Any information which is collected from the cardiac assessment including the health 
questionnaire, the ECG and the Echocardiogram will be analysed and kept strictly 
confidential. Data collected for the purpose of this study will be fully anonymised using 
codes with no way of linking data to you.  All data will be stored in a password 
protected computer file which only the clinical team (LHCH) and researchers (LJMU) 
will have access to.  
 
7. What will happen to the results of the study? 
 
After the tests are completed, your test results will be reported and a letter will be 
written by the consultant cardiologist to you and your doctor. This may be your club / 
sport doctor or your GP. If any further investigation should be necessary the consultant 
will make this clear in the letter. 
 
We are asking you to consent to the use of data from the health questionnaire, ECG and 
echocardiogram for research purposes. Results may be reported at national or 
international conferences and/or in journal publications but your identity will be 
protected and you will not be identified. 
 
 
8. What happens if something goes wrong on the day of my tests? 
 
If you have a concern about any aspect of this study, you should speak with the study 
team. Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed.  Please raise your concerns in the first 
instance with the Principal investigator, Dr David Oxborough and the contact details 
can be found below. 
 
9. Complaints procedure: 
 
If you have any concerns regarding your involvement in this research, please discuss 
these with the researcher in the first instance.  If you wish to make a complaint, please 
contact researchethics@ljmu.ac.uk and your communication will be re-directed to an 
independent person as appropriate. 
 
10. What Insurance Provisions are in place? 
 
In the unlikely event that something does go wrong and you are harmed during the 
research and this is due to someone’s negligence then you may have grounds for a legal 
action for compensation against Liverpool John Moores University but you may have to 
pay your legal costs.  
 
11. Who is organising the research? 
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This research is being organised by the principal investigator Dr David Oxborough, 
Research Institute for Sport and Exercise Sciences, Liverpool John Moores University 
in collaboration with Liverpool Heart and Chest Hospital.   The data collected from this 
study will be used to support PhD projects for two postgraduate research students within 
the Research Institute for Sport and Exercise Sciences – Mr Mohammad Qasem and Ms 
Lynsey Forsythe. The study has gained ethical approval from Liverpool John Moores 
University and the NHS research ethics committee. 
 
 
12. What happens now? 
 
If you choose to participate, you will be asked to complete an informed consent form on 
the day of your screening.  You will be asked to keep a copy of this information sheet 
and the signed consent forms.  
 
 
Thanks for your time. If you have any further questions or want to participate in 
the study please contact Mohammad Qasem or Lynsey Forsythe 
 
School of Sport and Exercise Sciences 
Tom Reilly Building 
Liverpool John Moores University 
Byrom Street 
Liverpool 
L33AF 
Email: M.E.Qasem@2014.ljmu.ac.uk or L.C.Forsythe@2014.ljmu.ac.uk 
 
 
Contact Details of Principal Investigator /Academic Supervisor  
 
Dr David Oxborough 
School of Sport and Exercise Sciences   
Tom Reilly Building 
Liverpool John Moores University 
Byrom Street 
Liverpool 
L33AF 
Email: D.L.Oxborough@ljmu.ac.uk 
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Appendix 3- Consent Form 
 
 
 
 
INFORMED CONSENT FORM (Athlete) 
 
 
Title of Project:  Differentiation of the Athlete’s heart from 
Cardiomyopathy (Heart Muscle Disease)  
Name of Principal Investigator:  Dr David Oxborough, Liverpool John Moores 
University, School of Sport and Exercise Sciences 
Centre Number:  
Study Number: 
Participant Identification Number: 
Thank you for reading the information about this collaborative research project  
between Liverpool Heart and Chest Hospital (LHCH) and Liverpool John Moores 
University (LJMU). If you would like to take part, please read and sign this form.  
 
                                                                                                                              Please 
initial all boxes 
 
 
1. I confirm that I have read and understand the information sheet (Version 
5, 20 January 2017) provided for the above study. I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily 
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving a reason and that this will not affect my legal rights. 
 
 
3. I understand that any personal information collected during the study will 
be anonymised and remain confidential 
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4. I agree to take part in the above study  
 
 
Name of Participant    Date    Signature 
 
 
 
Name of Researcher    Date   Signature 
 
 
 
Name of Person taking consent  Date   Signature 
(if different from researcher) 
 
 
 
 
 
 
 
 
Note: When completed 1 copy for participant and 1 copy for researcher 
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Appendix 4- Health Questionnaire 
Cardiac Screening Health 
Questionnaire 
 
 
   Participant Details 
 
Participant ID: Date of Screening: 
Age: Gender: 
 
 
Which country were you born in? 
………………………………………. Ethnicity (please tick the 
appropriate box) 
White Mixed Black Asian Other 
British  White and Black Caribbean  
 
Caribbean  Indian   Chinese  
Irish  White and Black African   East African 
 
Pakistani   Filipino  
European  White and Asian  West African 
 
Bangladeshi 
 
Vietnamese  
Turkish 
/Cypriot  
 North 
African  
 Other  
Greek /Cypriot 
 
    
If other, please state your ethnic origin: 
 
Height ……….cm Weight ………..Kg  Blood Pressure ………./……….mmHg 
 
 
1. Have you ever fainted? 
During 
Exercise 
Yes / No How recently did 
this occur? 
If yes, please describe the circumstances 
Following 
Exercise 
Yes / No How recently did 
this occur? 
Unrelated to 
exercise 
Yes / No How recently did 
this occur? 
 
 
2. Do you experience dizzy turns? 
During 
Exercise 
Yes / No How recently did 
this occur? 
If yes, please describe the circumstances 
Following 
Exercise 
Yes / No How recently did 
this occur? 
Unrelated to 
exercise 
Yes / No How recently did 
this occur? 
 
3. Do you experience palpitations? (palpitations are a fluttering in your chest that you can notice whilst   
resting) 
 
 
     Yes / No If yes, how recently and please describe the circumstances 
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4. Do you experience chest pain, heaviness or tightness? 
During Exercise Yes / No If yes, please describe the circumstances 
Following Exercise Yes / No 
Unrelated to exercise Yes / No 
 
5. Do you feel that you are more breathless or more easily tired than your team mates? 
     Yes / No If yes, please describe the circumstances 
 
6. Is there a family history of (please tick): 
High Blood Pressure □High Cholesterol □Diabetes □ 
7. Is there a family history of heart disease in anyone under the age of 50? 
     Yes / No      If yes, please state the age of onset 
 
 
8. Has anyone died suddenly in your family under the age 
of 50? 
 
     Yes / No If yes, please describe the circumstances and at what age 
did the death occur 
 
 
9. Approximately, how many days per week are you physically active (playing sport)? 
…………… 
 
10. On average, how many hours per week are you physically active (playing sport)? 
……….......... 
 
11. If you are competitive athlete what sports do you play and at what level? 
 
e.g. International, 
National, County, 
A (main sport)………… Level: …………… 
Club, Other B. ……………………………………. Level: …………… 
 
C.   ……………………………………. Level: …………… 
 
12. How long (for how many years) have you been participated in sport? 
……………………………. 
 
13. Do you agree for the results of your screening including investigations to be 
discussed with the Club doctor? Yes / No 
 
14. Do you agree for your results to be kept on a database for research in the 
future? Your personal identity will never be disclosed to anyone if your data is 
used for research.  Yes / No 
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Signature…………………………….                          Date………………… 
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 Appendix 6- Quality check list assessment (for study one)   
 1 2 3 4 5 6 7 8 Total 
Prakasa et al 
(2007) 
+ + + + + + + - 7 
Tops et al + + + + - - + - 5 
Wang et al + + + + - - + - 5 
Teske et al 
(2009) 
+ + + + + + + + 8 
Bauce et al + + + + - + + - 6 
Iacoviello et al + + + + - - + - 5 
Aneq et al + + + + - - + - 5 
vitarelli et al + + + + + + + - 7 
Lindstrom et al + + + + + + + - 7 
Yoerger et al + + + + - - + - 5 
 10 10 10 10 4 5 10 1 Total 
+ Represents criteria achieved and one point is given. 
− Represents criteria not achieved. 
No. criteria: 
1. Matched Control Group 
2. Task Force Criteria 
3. Participant Concent / Ethical approval 
4. Echocardiography Protocol 
5. Medication 
6. Patient States 
7. Eligibility criteria were specified 
8. Genotype Detected 
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Appendix 7- Supplementary Table (for study two)  
 
Regional RV Strain (ε) (%) and Strain Rate (SR) (l/s) including base to apex gradients 
(data are mean ± SD) 
Base to apex ε gradient (%) 
 and SR (l/s) 
LD MD HD 
 lateral Wall:  
Basal ε -26.4 ± 6.6 -26.4 ± 7.1 -25.9 ± 5.5 
Basal SRS'  -2.1 ± 0.8
^ 
-1.9 ± 0.6 -1.7 ± 0.5 
Basal SRE'  2.5 ± 0.9 2.3 ± 0.8 2.2 ± 0.7 
Basal SRA' 1.1 0.4 1.2 0.5 1.3 0.4 
Mid ε -27.3 ± 4.8 -27.3 ± 5.4 -27.8 ± 4.2 
Mid SRS' -1.4 ± 0.3 -1.6 ± 0.4 -1.4 ± 0.3 
Mid SRE' 1.9 ± 0.5 1.8 ± 0.5 1.9 ± 0.4 
Mid SRA' 0.9 ± 0.3 1 ± 0.4 0.9 ± 0.3 
Apical ε -30.9 ± 4.5 -28.7 ± 5 -31.4 ± 4.9¶ 
Apical SRS' -2 ± 0.5 -1.8 ± 0.5 -1.9 ± 0.6 
Apical SRE' 2.5 ± 0.6 2.1 ± 0.7 2.5 ± 0.6
§ 
Apical SRA' 1.2 ± 0.5 1.3 ± 0.4 1.3 ± 0.4 
 Septal Wall:  
Basal ε -17.6 ± 2.7 -18.6 ± 2.7 -18 ± 3.1 
Basal SRS' -1.2 ± 0.3 -1.2 ± 0.2 -1.2 ± 0.3 
Basal SRE' 1.6 ± 0.4 1.5 ± 0.4 1.6 ± 0.4 
Basal SRA' 0.8 ± 0.2 0.7 ± 0.3 0.7 ± 0.3 
Mid ε -18.3 ± 3.1 -17.8 ± 2.5 -17.6 ± 2.5 
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Mid SRS' -1.1 ± 0.3 -1 ± 0.2 -0.9 ± 0.2 
Mid SRE' 1.8 ± 0.4 1.5 ± 0.4 1.6 ± 0.4 
Mid SRA' 0.7 ± 0.2 0.6 ± 0.2 0.6 ± 0.2 
Apical ε -22.9 ± 4.5* -18.8 ± 4.8 -21.5 ± 4.7¶ 
Apical SRS' -1.9 ± 0.7 -1.7 ± 0.7 -1.8 ± 0.9 
Apical SRE' 2.3 ± 0.5 1.9 ± 0.6 2.1 ± 0.6 
Apical SRA' 0.9 ± 0.4 0.8 ± 0.4 0.8 ± 0.3 
*
P <0.01: LD versus MD;
§
P <0.01: MD versus HD ; 
¶
 P <0.01: HD versus MD; ^ P 
<0.01: LD versus HD 
 
 
